≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other and unspecified hydrocephalus

DOID EFO Endpoint Browser PheWeb

G6_HCOTHUNS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G91.8, G91.9
  • Hospital discharge: ICD-8 — 34793
  • Cause of death: ICD-10 — G91.8, G91.9
  • Cause of death: ICD-8 — 34793

2 out of 7 registries used, show all original rules.

718

4. Check minimum number of events

None

718

5. Include endpoints

None

718

6. Filter based on genotype QC (FinnGen only)

695

Control definitions (FinnGen only)

Control exclude
G6_HYDROCEPH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6159 3013 3080
Only index persons 4640 2370 2270
Unadjusted period prevalence (%)
Whole population 0.09 0.09 0.09
Only index persons 0.09 0.09 0.09
Median age at first event (years)
Whole population 56.12 58.51 53.59
Only index persons 54.55 57.40 51.57

-FinnGen-

Key figures

All Female Male
Number of individuals 695 385 310
Unadjusted period prevalence (%) 0.14 0.14 0.14
Median age at first event (years) 60.92 59.32 62.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
718
Matched controls
7180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
6268.7
307.7
354
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
307.7
574
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
307.7
288
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
2765.6
207.7
191
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
200.7
183
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
200.7
183
*
AA1AA
NOMESCO Finland
Head X-ray examination
64.8
197.7
110
20
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
18.4
193.3
168
117
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
181.1
166
*
AA1AD
NOMESCO Finland
CT of head and brain
7.1
149.2
475
1546
AAF00
NOMESCO Finland
Ventriculostomy
538.3
138.2
133
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
133.6
124
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.3
109.4
191
338
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
104.8
98
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
100.4
94
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
30.5
95.8
64
23
N03AX14
ATC
levetiracetam; systemic
13.2
87.4
87
74
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.4
75.1
177
408
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
74.3
70
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
16.6
70.8
61
40
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.5
69.5
108
165
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
735.6
69.2
67
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.4
67.2
78
83
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
11.5
63.9
69
66
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.3
62.2
145
328
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.0
61.4
80
99
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.2
55.1
60
58
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
53.8
51
*
R51.80
ICD-10 Finland
Headache
3.8
52.7
206
686
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.5
45.9
52
53
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
7.0
45.6
73
114
N03AG01
ATC
valproic acid; systemic, rectal
5.2
45.1
102
222
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
43.8
238
962
N29
ICPC
Neurological sympt/complt other
10.4
41.4
47
48
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
13.7
41.1
39
30
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
408.8
39.5
39
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
13.3
39.5
38
30
ZXD05
NOMESCO Finland
Urgent procedure
2.8
39.1
299
1445
XA800
NOMESCO Finland
Neuropsychological investigation
5.6
36.6
74
145
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
10.5
35.7
40
40
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
13.9
34.1
32
24
34793
ICD-8 Finland
Other disease of brain, Hydrocephalus acquisitus NUD
+∞
33.6
32
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
33.5
105
294
N03AF02
ATC
oxcarbazepine; oral
6.5
33.2
56
92
TAB00
NOMESCO Finland
Lumbar puncture
5.0
32.0
73
159
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
31.9
192
805
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.3
31.8
43
55
N18
ICPC
Paralysis/weakness
8.3
31.8
43
55
N28
ICPC
Limited function/disability (N)
8.8
31.1
40
48
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
326.4
31.1
31
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
29.1
172
710
N99
ICPC
Neurological disease other
10.8
29.1
32
31
L28
ICPC
Limited function/disability (L)
2.7
28.7
209
961
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
+∞
27.3
26
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
25.0
27.3
38
16
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.4
27.1
36
45
G04BD07
ATC
tolterodine; oral
4.2
26.4
74
190
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.3
25.2
69
174
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
24.3
318
1874
2132
FHL
Ventricular operators sunt
+∞
24.1
23
*
F03
ICD-10 Finland
Unspecified dementia
4.1
23.9
69
181
A28
ICPC
Limited function/disability NOS
2.4
23.1
202
999
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
23.0
22
*
R42
ICD-10 Finland
Dizziness and giddiness
2.3
23.0
225
1169
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.7
22.9
77
225
SPAT1229
SPAT
Assessment of need for aid
3.3
22.3
91
301
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
22.3
22.3
32
15
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
7.3
22.2
33
47
K90
ICPC
Stroke/cerebrovascular accident
5.1
22.1
48
100
G91.3
ICD-10 Finland
Post-traumatic hydrocephalus, unspecified
+∞
22.0
21
*
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
+∞
20.9
20
*
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
+∞
20.9
20
*
SPAT1216
SPAT
Assessment of functional ability
2.5
20.9
161
748
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
6.7
20.6
33
51
N03AB02
ATC
phenytoin; systemic
7.7
20.5
29
39
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
20.3
113
446
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
20.2
224
1217
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
20.1
31
46
G93.0
ICD-10 Finland
Cerebral cysts
36.9
19.9
25
7
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
15.9
19.9
32
21
2133
FHL
Suntin revisio
+∞
19.9
19
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.4
19.8
40
78
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
19.8
87
301
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
6.1
19.3
34
58
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
194.9
18.6
19
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
5.9
18.2
33
58
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
15.1
17.7
29
20
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
17.7
152
737
G93.2
ICD-10 Finland
Benign intracranial hypertension
97.5
17.6
19
*
H47.2
ICD-10 Finland
Optic atrophy
32.4
17.1
22
7
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
17.1
280
1741
R53
ICD-10 Finland
Malaise and fatigue
2.1
16.9
225
1298
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
64.9
16.8
19
*
G91
ICD-10 Finland
Hydrocephalus
+∞
16.7
16
*
PA2AD
NOMESCO Finland
CT angiography of brain
16.8
16.7
26
16
G04BD08
ATC
solifenacin; oral
3.0
16.6
78
280
H53.4
ICD-10 Finland
Visual field defects
5.2
15.9
33
66
R41.0
ICD-10 Finland
Disorientation, unspecified
4.1
15.6
44
113
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
15.2
15.4
25
17
N05BA09
ATC
clobazam; oral
15.2
15.4
25
17
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.7
15.3
87
346
U04
ICPC
Incontinence urine
3.0
15.3
71
253
P20
ICPC
Memory disturbance
2.2
15.0
144
727
WX730
NOMESCO Finland
Conventional respirator
6.7
15.0
24
37
N03AX18
ATC
lacosamide; systemic
15.5
15.0
24
16
N05CD08
ATC
midazolam; nasal, systemic
4.6
14.9
36
82
N05AH03
ATC
olanzapine; systemic
3.1
14.9
66
229
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
57.9
14.8
17
*
N06AB04
ATC
citalopram; systemic
2.1
14.8
174
951
Q03.0
ICD-10 Finland
Malformations of aqueduct of Sylvius
+∞
14.6
14
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
27.8
14.3
19
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
14.3
108
492
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
14.3
128
628
R32
ICD-10 Finland
Unspecified urinary incontinence
4.4
14.2
36
85
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.8
14.2
26
46
M03BX01
ATC
baclofen; systemic
5.1
14.2
30
61
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.7
14.1
46
131
N30.0
ICD-10 Finland
Acute cystitis
2.1
14.1
149
781
N05AH04
ATC
quetiapine; oral
2.1
14.0
150
791
N05BA01
ATC
diazepam; systemic, rectal
2.3
13.9
119
573
N03AX09
ATC
lamotrigine; oral
3.5
13.8
48
143
A06AD11
ATC
lactulose; oral
2.1
13.7
143
746
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
13.6
80
323
7423A
ICD-9 Finland
Other congenital anomalies of nervous system, Congenital hydrocephalus
+∞
13.6
13
*
S06.0
ICD-10 Finland
Concussion
2.4
13.5
107
497
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
142.6
13.5
14
*
SPAT1301
SPAT
No procedures
1.9
13.2
252
1617
N05AX08
ATC
risperidone; systemic
2.4
13.2
95
423
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
13.2
100
456
183
Kela drug reimbursment
Lamotrigin and topiramate
11.2
13.1
24
22
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
13.1
108
511
R11
ICD-10 Finland
Nausea and vomiting
2.5
13.0
90
393
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
13.0
42
119
ZXC86
NOMESCO Finland
Use of endoscopic device
23.0
12.9
18
8
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
12.9
137
717
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
12.9
92
408
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
10.8
12.8
24
23
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
12.8
145
778
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.3
12.8
105
495
WX882
NOMESCO Finland
High dependency care
3.9
12.7
38
102
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
15.8
12.7
20
13
2130
FHL
Ventricular atrial shunt
+∞
12.5
12
*
74200
ICD-8 Finland
Congenital hydrocephalus, Communicans
+∞
12.5
12
*
H47.1
ICD-10 Finland
Papilloedema, unspecified
13.5
12.5
21
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
12.5
163
921
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.4
12.4
45
138
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
16.2
12.2
19
12
SPAT1254
SPAT
Administration of medicine
2.1
12.1
131
690
XCK00
NOMESCO Finland
Perimetry
2.9
12.0
60
222
R50.9
ICD-10 Finland
Fever, unspecified
2.1
12.0
132
700
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.5
12.0
41
121
N03AF01
ATC
carbamazepine; oral, rectal
3.0
11.9
55
195
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
6.0
11.9
21
36
WX402
NOMESCO Finland
General anaesthesia
1.9
11.8
169
984
SPAT1262
SPAT
Handing over of treatment supplies
2.0
11.7
139
758
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
23.3
11.6
16
7
N05AB03
ATC
perphenazine; systemic, rectal
3.7
11.6
37
104
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.4
11.5
82
363
T85.7
ICD-10 Finland
Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
121.9
11.5
12
*
G81.1
ICD-10 Finland
Spastic hemiplegia
121.9
11.5
12
*
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
4.2
11.4
30
73
H53.2
ICD-10 Finland
Diplopia
3.6
11.4
38
110
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.7
11.3
62
241
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.3
11.3
44
141
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.5
11.3
73
309
SPAT1167
SPAT
Insertion of urinary catheter
3.7
11.2
35
97
XKC03
NOMESCO Finland
Water cystometry
3.7
11.2
35
97
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.8
11.1
20
35
N06DA02
ATC
donepezil; oral
2.5
11.0
72
306
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.6
10.9
63
252
T90.5
ICD-10 Finland
Sequelae of intracranial injury
8.2
10.7
23
29
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
60.9
10.6
12
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
10.6
67
1407
SPAT1053
SPAT
Memory test
2.0
10.5
126
687
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
10.4
10
*
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
+∞
10.4
10
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.7
10.3
24
53
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
10.2
220
1445
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.3
10.2
26
62
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
10.1
151
888
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
3.0
9.9
45
158
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.8
9.9
52
198
G04BD12
ATC
mirabegron; oral
2.0
9.8
109
577
GBB00
NOMESCO Finland
Tracheostomy
8.0
9.7
21
27
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
55.8
9.7
11
*
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
4.7
9.6
22
48
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
15.3
9.5
15
10
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
101.3
9.4
10
*
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
101.3
9.4
10
*
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
101.3
9.4
10
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
30.5
9.4
12
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
5.2
9.4
19
37
K91
ICPC
Cerebrovascular disease
5.2
9.4
19
37
AAK80
NOMESCO Finland
Partial excision of skull cap
+∞
9.4
9
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
12.6
9.4
16
13
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.0
9.4
26
66
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
22.0
9.4
13
6
N02AA05
ATC
oxycodone; systemic
1.8
9.2
154
935
WX704
NOMESCO Finland
Intubation
2.4
9.2
65
287
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.1
9.1
19
38
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
8.5
9.1
19
23
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.2
9.1
21
30
G40.10
ICD-10 Finland
Simple partial seizures
10.2
9.1
17
17
G81.9
ICD-10 Finland
Hemiplegia, unspecified
7.6
9.0
20
27
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.8
8.9
20
43
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
10.9
8.8
16
15
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
9.6
8.8
17
18
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.3
8.7
22
52
ZXD00
NOMESCO Finland
Emergency procedure
3.7
8.6
27
75
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
8.6
53
219
R60.0
ICD-10 Finland
Localized oedema
2.0
8.6
106
583
Z2445
NOMESCO Finland
Psychologist
2.9
8.5
39
138
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
27.9
8.5
11
*
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.4
8.4
21
49
AAF45
NOMESCO Finland
Fenestration of intracranial cyst
+∞
8.3
8
*
J01EA01
ATC
trimethoprim; systemic
1.7
8.3
194
1291
WYA20
NOMESCO Finland
Home visit
3.8
8.2
25
68
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.6
8.2
27
78
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
10.2
8.1
15
15
N06AX11
ATC
mirtazapine; oral
1.6
8.0
246
1754
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.4
8.0
18
25
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.1
7.8
18
26
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
7.1
7.8
18
26
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.7
7.8
24
66
N06AB10
ATC
escitalopram; oral
1.8
7.8
138
850
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.6
7.8
25
71
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
45.5
7.7
9
*
ABE50
NOMESCO Finland
Occipitocervical decompression
45.5
7.7
9
*
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
45.5
7.7
9
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
7.7
104
588
G04BD04
ATC
oxybutynin; oral, transdermal
2.3
7.7
57
257
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
7.6
207
1428
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
18.6
7.6
11
6
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
7.6
103
583
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
25.3
7.6
10
*
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
25.3
7.6
10
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
25.3
7.6
10
*
R5110, ,
SPAT
2.1
7.6
76
387
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
10.2
7.6
14
14
L29
ICPC
Musculoskeletal sympt/complt other
2.1
7.5
74
375
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.0
7.5
21
54
S01EC01
ATC
acetazolamide; systemic
3.4
7.4
26
78
G20
ICD-10 Finland
Parkinson disease
3.1
7.4
31
104
D33.30
ICD-10 Finland
Acoustic neuroma
13.5
7.4
12
9
R33
ICD-10 Finland
Retention of urine
2.1
7.4
71
356
N06AX16
ATC
venlafaxine; oral
1.9
7.4
101
574
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
9.5
7.3
14
15
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
7.3
105
606
2139
FHL
Other measure in this category
+∞
7.3
7
*
AAW99
NOMESCO Finland
Other intracranial operation
+∞
7.3
7
*
G94.1
ICD-10 Finland
Hydrocephalus in neoplastic disease
+∞
7.3
7
*
XKD00
NOMESCO Finland
Uroflowmetry
1.8
7.3
109
637
G03.9
ICD-10 Finland
Meningitis, unspecified
15.9
7.2
11
7
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.5
7.2
24
70
G04BD09
ATC
trospium; oral
3.3
7.2
26
80
N03AE01
ATC
clonazepam; systemic
2.5
7.2
45
188
R26.0
ICD-10 Finland
Ataxic gait
20.3
7.1
10
5
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
6.7
7.1
17
26
Z02.7
ICD-10 Finland
Issue of medical certificate
2.2
7.1
61
292
R27.0
ICD-10 Finland
Ataxia, unspecified
12.2
7.1
12
10
F06.7
ICD-10 Finland
Mild cognitive disorder
2.9
7.1
33
118
N04AA02
ATC
biperiden; systemic
3.9
7.0
20
52
N80
ICPC
Head injury other
3.3
6.9
25
77
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.5
6.9
41
167
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.9
119
727
SPAT1234
SPAT
Support of social functional capacity
2.4
6.8
47
205
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
9.4
6.8
13
14
F22.0
ICD-10 Finland
Delusional disorder
5.7
6.8
18
32
R55
ICD-10 Finland
Syncope and collapse
1.9
6.6
93
532
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
12.4
6.6
11
9
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.8
6.5
32
118
N30.9
ICD-10 Finland
Cystitis, unspecified
2.2
6.5
56
269
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.0
6.5
18
46
Q04.6
ICD-10 Finland
Congenital cerebral cysts
70.5
6.4
7
*
SPAT1240
SPAT
Therapeutic discussion
2.0
6.4
67
347
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
2.7
6.4
34
131
ZXA00
NOMESCO Finland
Right side
1.6
6.3
192
1352
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.7
6.3
33
126
SPAT1260
SPAT
Consultation of another employee
1.7
6.3
123
776
ZXD35
NOMESCO Finland
Usual procedure
2.9
6.3
28
98
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
6.3
6
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
6.3
6
*
74209
ICD-8 Finland
Congenital hydrocephalus, Unspecified
+∞
6.3
6
*
P52.2
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newborn
+∞
6.3
6
*
AAK85
NOMESCO Finland
Replantation of previously excised part of skull cap
+∞
6.3
6
*
G41.2
ICD-10 Finland
Complex partial status epilepticus
26.9
6.2
8
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
3.0
6.2
27
93
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
6.2
114
707
S72.0
ICD-10 Finland
Fracture of neck of femur
2.4
6.2
40
170
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
7.8
6.1
13
17
OAB43, ,
SPAT
0.5
6.1
58
1073
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.1
28
100
G40.89
ICD-10 Finland
Other epilepsy
10.1
6.0
11
11
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.3
6.0
17
33

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Neurosurgery
14 [38004459]
2.4e+00
3.7e+00
4.8e+00
1.0e+50
5.2e+00
5.5e+00
3.7e+00
cases:18.57%
controls:2.00%
cases:27.85%
controls:0.95%
cases:15.41%
controls:0.15%
cases:50.52%
controls:0.00%
cases:23.72%
controls:0.18%
cases:66.07%
controls:0.78%
cases:45.61%
controls:2.01%
125
134
548
6557
188
64
487
6642
104
10
571
6696
341
0
334
6706
158
12
508
6683
409
51
210
6495
244
115
291
5602
Inpatient Hospital
21 [8717]
6.9e-01
1.5e+00
2.7e+00
6.7e+00
3.1e+00
1.9e+00
1.1e+00
cases:49.93%
controls:33.31%
cases:37.63%
controls:11.63%
cases:19.85%
controls:1.69%
cases:37.93%
controls:0.07%
cases:28.53%
controls:1.76%
cases:45.72%
controls:11.46%
cases:53.27%
controls:28.41%
336
2229
337
4462
254
780
421
5926
134
113
541
6593
256
5
419
6701
190
118
476
6577
283
750
336
5796
285
1624
250
4093
Neurology
13 [38004458]
1.3e+00
2.6e+00
3.3e+00
—
3.8e+00
3.1e+00
2.3e+00
cases:28.38%
controls:9.77%
cases:38.22%
controls:4.31%
cases:18.67%
controls:0.84%
—
—
cases:23.12%
controls:0.69%
cases:47.82%
controls:4.08%
cases:54.39%
controls:10.97%
191
654
482
6037
258
289
417
6417
126
56
549
6650
—
154
46
512
6649
296
267
323
6279
291
627
244
5090
General Practice
1 [38004446]
8.1e-01
1.6e+00
1.9e+00
4.4e+00
3.0e+00
1.7e+00
9.1e-01
cases:23.33%
controls:11.97%
cases:21.93%
controls:5.26%
cases:6.67%
controls:1.01%
cases:5.48%
controls:0.07%
cases:16.07%
controls:0.96%
cases:25.36%
controls:6.06%
cases:33.64%
controls:17.00%
157
801
516
5890
148
353
527
6353
45
68
630
6638
37
5
638
6701
107
64
559
6631
157
397
462
6149
180
972
355
4745
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
1.8e+00
2.1e+00
2.2e+00
—
2.3e+00
2.4e+00
2.3e+00
cases:4.46%
controls:0.73%
cases:4.30%
controls:0.55%
cases:2.37%
controls:0.27%
—
—
cases:2.70%
controls:0.27%
cases:5.98%
controls:0.57%
cases:7.48%
controls:0.82%
30
49
643
6642
29
37
646
6669
16
18
659
6688
—
18
18
648
6677
37
37
582
6509
40
47
495
5670
Respiratory and circulatory monitoring
WX700 [2001310817]
9.1e-01
1.9e+00
3.1e+00
1.0e+50
2.8e+00
2.3e+00
1.3e+00
cases:5.05%
controls:2.09%
cases:3.85%
controls:0.58%
cases:1.63%
controls:0.07%
cases:3.56%
controls:0.00%
cases:2.55%
controls:0.16%
cases:5.65%
controls:0.63%
cases:7.10%
controls:1.99%
34
140
639
6551
26
39
649
6667
11
5
664
6701
24
0
651
6706
17
11
649
6684
35
41
584
6505
38
114
497
5603
Abdominal X-ray examination without contrast
JN3AA [2001305553]
2.2e+00
3.5e+00
1.0e+50
1.0e+50
—
3.4e+00
3.1e+00
cases:2.82%
controls:0.31%
cases:2.96%
controls:0.09%
cases:1.63%
controls:0.00%
cases:2.67%
controls:0.00%
—
—
cases:5.01%
controls:0.18%
cases:5.42%
controls:0.26%
19
21
654
6670
20
6
655
6700
11
0
664
6706
18
0
657
6706
—
31
12
588
6534
29
15
506
5702
levetiracetam; oral, parenteral
N03AX14 [21604436]
2.3e+00
2.1e+00
2.1e+00
—
—
2.9e+00
2.7e+00
cases:2.38%
controls:0.25%
cases:2.67%
controls:0.34%
cases:1.04%
controls:0.13%
—
—
—
—
cases:5.33%
controls:0.32%
cases:5.23%
controls:0.38%
16
17
657
6674
18
23
657
6683
7
9
668
6697
—
—
33
21
586
6525
28
22
507
5695
Supine thorax X-ray examination
GD1QA [2001303648]
1.0e+00
2.0e+00
2.6e+00
1.0e+50
3.3e+00
1.5e+00
1.1e+00
cases:3.57%
controls:1.35%
cases:4.44%
controls:0.63%
cases:1.63%
controls:0.12%
cases:4.30%
controls:0.00%
cases:3.00%
controls:0.12%
cases:3.72%
controls:0.86%
cases:8.41%
controls:2.89%
24
90
649
6601
30
42
645
6664
11
8
664
6698
29
0
646
6706
20
8
646
6687
23
56
596
6490
45
165
490
5552
Cerebral aneurysm, nonruptured
I67.1 [45538401]
2.3e+00
3.2e+00
—
1.0e+50
—
3.1e+00
2.9e+00
cases:1.78%
controls:0.18%
cases:1.78%
controls:0.07%
—
—
cases:1.63%
controls:0.00%
—
—
cases:2.26%
controls:0.11%
cases:3.18%
controls:0.17%
12
12
661
6679
12
5
663
6701
—
11
0
664
6706
—
14
7
605
6539
17
10
518
5707
More than one and less than three hours
ZXE10 [2001311401]
4.8e-01
1.4e+00
2.4e+00
1.0e+50
3.9e+00
2.2e+00
1.2e+00
cases:8.92%
controls:5.71%
cases:5.04%
controls:1.24%
cases:1.48%
controls:0.13%
cases:5.33%
controls:0.00%
cases:4.20%
controls:0.09%
cases:10.82%
controls:1.34%
cases:12.71%
controls:4.20%
60
382
613
6309
34
83
641
6623
10
9
665
6697
36
0
639
6706
28
6
638
6689
67
88
552
6458
68
240
467
5477
oxcarbazepine; oral
N03AF02 [21604418]
2.1e+00
2.2e+00
2.0e+00
—
—
2.5e+00
2.3e+00
cases:2.97%
controls:0.37%
cases:2.67%
controls:0.31%
cases:0.89%
controls:0.12%
—
—
—
—
cases:3.23%
controls:0.27%
cases:4.11%
controls:0.44%
20
25
653
6666
18
21
657
6685
6
8
669
6698
—
—
20
18
599
6528
22
25
513
5692
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.4e+00
3.4e+00
—
1.0e+50
—
3.6e+00
2.5e+00
cases:2.53%
controls:0.64%
cases:4.30%
controls:0.15%
—
—
cases:3.26%
controls:0.00%
—
—
cases:4.85%
controls:0.14%
cases:7.10%
controls:0.61%
17
43
656
6648
29
10
646
6696
—
22
0
653
6706
—
30
9
589
6537
38
35
497
5682
Dizziness and giddiness
R42 [45568132]
1.2e+00
1.9e+00
2.8e+00
1.0e+50
2.3e+00
1.8e+00
8.6e-01
cases:8.47%
controls:2.62%
cases:5.63%
controls:0.92%
cases:1.48%
controls:0.09%
cases:1.63%
controls:0.00%
cases:1.35%
controls:0.13%
cases:5.98%
controls:1.07%
cases:8.41%
controls:3.73%
57
175
616
6516
38
62
637
6644
10
6
665
6700
11
0
664
6706
9
9
657
6686
37
70
582
6476
45
213
490
5504
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
1.8e+00
3.0e+00
—
1.0e+50
—
3.5e+00
2.4e+00
cases:4.01%
controls:0.66%
cases:5.33%
controls:0.27%
—
—
cases:4.44%
controls:0.00%
—
—
cases:6.30%
controls:0.20%
cases:8.41%
controls:0.80%
27
44
646
6647
36
18
639
6688
—
30
0
645
6706
—
39
13
580
6533
45
46
490
5671
Inpatient Visit
IP [9201]
6.1e-01
1.3e+00
2.4e+00
1.0e+50
3.5e+00
1.8e+00
9.4e-01
cases:8.32%
controls:4.68%
cases:7.85%
controls:2.18%
cases:2.81%
controls:0.25%
cases:4.74%
controls:0.00%
cases:7.06%
controls:0.24%
cases:11.79%
controls:2.08%
cases:15.33%
controls:6.61%
56
313
617
6378
53
146
622
6560
19
17
656
6689
32
0
643
6706
47
16
619
6679
73
136
546
6410
82
378
453
5339
Outpatient Hospital
22 [8756]
5.9e-01
1.4e+00
2.7e+00
—
2.8e+00
2.0e+00
9.9e-01
cases:38.78%
controls:25.93%
cases:24.44%
controls:7.62%
cases:11.56%
controls:0.91%
—
—
cases:14.26%
controls:0.96%
cases:38.29%
controls:7.53%
cases:41.68%
controls:20.92%
261
1735
412
4956
165
511
510
6195
78
61
597
6645
—
95
64
571
6631
237
493
382
6053
223
1196
312
4521
Outpatient Visit
OP [9202]
5.4e-01
9.5e-01
8.9e-01
4.4e+00
1.1e+00
1.7e+00
9.3e-01
cases:79.05%
controls:68.75%
cases:70.96%
controls:48.67%
cases:23.26%
controls:11.05%
cases:29.04%
controls:0.49%
cases:26.43%
controls:10.90%
cases:83.68%
controls:48.96%
cases:89.72%
controls:77.58%
532
4600
141
2091
479
3264
196
3442
157
741
518
5965
196
33
479
6673
176
730
490
5965
518
3205
101
3341
480
4435
55
1282
Paediatric neurology
421 [44777781]
2.1e+00
2.7e+00
—
—
—
2.8e+00
2.8e+00
cases:1.78%
controls:0.22%
cases:1.78%
controls:0.12%
—
—
—
—
—
—
cases:1.78%
controls:0.11%
cases:3.18%
controls:0.19%
12
15
661
6676
12
8
663
6698
—
—
—
11
7
608
6539
17
11
518
5706
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
2.3e+00
2.5e+00
—
—
—
2.7e+00
2.8e+00
cases:2.23%
controls:0.22%
cases:1.48%
controls:0.12%
—
—
—
—
—
—
cases:1.62%
controls:0.11%
cases:2.99%
controls:0.19%
15
15
658
6676
10
8
665
6698
—
—
—
10
7
609
6539
16
11
519
5706
solifenacin; oral
G04BD08 [21602641]
1.6e+00
2.6e+00
2.7e+00
—
—
2.2e+00
1.2e+00
cases:3.86%
controls:0.78%
cases:3.41%
controls:0.27%
cases:1.33%
controls:0.09%
—
—
—
—
cases:2.75%
controls:0.32%
cases:3.74%
controls:1.12%
26
52
647
6639
23
18
652
6688
9
6
666
6700
—
—
17
21
602
6525
20
64
515
5653
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
2.1e+00
2.6e+00
—
—
—
3.0e+00
2.5e+00
cases:1.49%
controls:0.18%
cases:1.63%
controls:0.12%
—
—
—
—
—
—
cases:1.45%
controls:0.08%
cases:3.18%
controls:0.26%
10
12
663
6679
11
8
664
6698
—
—
—
9
5
610
6541
17
15
518
5702
Limited function/disability (L)
L28 [2002000647]
9.8e-01
1.7e+00
2.2e+00
—
2.1e+00
2.0e+00
1.1e+00
cases:4.61%
controls:1.78%
cases:3.70%
controls:0.67%
cases:1.63%
controls:0.18%
—
—
cases:1.05%
controls:0.13%
cases:5.49%
controls:0.78%
cases:9.91%
controls:3.64%
31
119
642
6572
25
45
650
6661
11
12
664
6694
—
7
9
659
6686
34
51
585
6495
53
208
482
5509
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
1.3e+00
1.4e+00
2.7e+00
1.0e+50
3.1e+00
1.4e+00
6.7e-01
cases:2.97%
controls:0.79%
cases:1.78%
controls:0.46%
cases:1.33%
controls:0.09%
cases:1.63%
controls:0.00%
cases:1.65%
controls:0.07%
cases:2.26%
controls:0.57%
cases:4.30%
controls:2.26%
20
53
653
6638
12
31
663
6675
9
6
666
6700
11
0
664
6706
11
5
655
6690
14
37
605
6509
23
129
512
5588
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
6.3e-01
1.3e+00
2.7e+00
1.0e+50
3.2e+00
1.3e+00
8.0e-01
cases:7.13%
controls:3.93%
cases:5.19%
controls:1.49%
cases:2.07%
controls:0.15%
cases:1.93%
controls:0.00%
cases:2.40%
controls:0.10%
cases:6.14%
controls:1.70%
cases:12.52%
controls:6.02%
48
263
625
6428
35
100
640
6606
14
10
661
6696
13
0
662
6706
16
7
650
6688
38
111
581
6435
67
344
468
5373
Rehabilitation Hospital
283X00000X [38004285]
1.7e+00
2.7e+00
—
—
—
3.3e+00
2.1e+00
cases:1.93%
controls:0.36%
cases:1.48%
controls:0.10%
—
—
—
—
—
—
cases:2.91%
controls:0.11%
cases:3.18%
controls:0.38%
13
24
660
6667
10
7
665
6699
—
—
—
18
7
601
6539
17
22
518
5695
Traumatic subdural haemorrhage
S06.5 [45563422]
2.0e+00
2.5e+00
1.0e+50
1.0e+50
—
3.1e+00
2.1e+00
cases:1.78%
controls:0.25%
cases:2.37%
controls:0.19%
cases:1.19%
controls:0.00%
cases:1.04%
controls:0.00%
—
—
cases:3.07%
controls:0.14%
cases:3.18%
controls:0.38%
12
17
661
6674
16
13
659
6693
8
0
667
6706
7
0
668
6706
—
19
9
600
6537
17
22
518
5695
General anesthesia, balanced
WX408 [2001310808]
6.8e-01
1.6e+00
—
1.0e+50
3.7e+00
2.4e+00
1.3e+00
cases:6.24%
controls:3.27%
cases:3.85%
controls:0.82%
—
—
cases:4.30%
controls:0.00%
cases:3.00%
controls:0.07%
cases:6.62%
controls:0.61%
cases:8.97%
controls:2.57%
42
219
631
6472
26
55
649
6651
—
29
0
646
6706
20
5
646
6690
41
40
578
6506
48
147
487
5570
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.7e+00
2.9e+00
—
1.0e+50
—
2.8e+00
2.2e+00
cases:3.57%
controls:0.66%
cases:4.30%
controls:0.25%
—
—
cases:1.33%
controls:0.00%
—
—
cases:5.01%
controls:0.32%
cases:7.29%
controls:0.82%
24
44
649
6647
29
17
646
6689
—
9
0
666
6706
—
31
21
588
6525
39
47
496
5670
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 [3027475]
2.6e+00
3.9e+00
1.0e+50
1.0e+50
1.0e+50
—
3.2e+00
cases:3.71%
controls:0.28%
cases:6.07%
controls:0.13%
cases:1.19%
controls:0.00%
cases:2.52%
controls:0.00%
cases:9.01%
controls:0.00%
—
—
cases:6.92%
controls:0.31%
25
19
648
6672
41
9
634
6697
8
0
667
6706
17
0
658
6706
60
0
606
6695
—
37
18
498
5699
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 [3016543]
2.6e+00
3.9e+00
1.0e+50
1.0e+50
1.0e+50
—
3.2e+00
cases:3.71%
controls:0.28%
cases:6.07%
controls:0.13%
cases:1.19%
controls:0.00%
cases:2.52%
controls:0.00%
cases:9.01%
controls:0.00%
—
—
cases:6.92%
controls:0.31%
25
19
648
6672
41
9
634
6697
8
0
667
6706
17
0
658
6706
60
0
606
6695
—
37
18
498
5699
Internal Medicine
11 [38004456]
4.5e-01
7.3e-01
1.6e+00
4.2e+00
1.5e+00
6.2e-01
5.8e-01
cases:31.50%
controls:22.63%
cases:19.11%
controls:10.26%
cases:8.44%
controls:1.83%
cases:6.37%
controls:0.10%
cases:7.81%
controls:1.94%
cases:17.12%
controls:9.96%
cases:35.33%
controls:23.37%
212
1514
461
5177
129
688
546
6018
57
123
618
6583
43
7
632
6699
52
130
614
6565
106
652
513
5894
189
1336
346
4381
Office Visit
OMOP4822458 [581477]
4.6e-01
1.3e+00
2.2e+00
1.0e+50
2.8e+00
1.6e+00
1.2e+00
cases:14.12%
controls:9.37%
cases:10.37%
controls:3.00%
cases:3.11%
controls:0.36%
cases:4.00%
controls:0.00%
cases:6.31%
controls:0.39%
cases:12.76%
controls:2.93%
cases:22.06%
controls:8.22%
95
627
578
6064
70
201
605
6505
21
24
654
6682
27
0
648
6706
42
26
624
6669
79
192
540
6354
118
470
417
5247
Home Visit
OMOP4822459 [581476]
9.3e-01
1.5e+00
1.8e+00
1.4e+00
1.3e+00
1.5e+00
1.2e+00
cases:9.06%
controls:3.77%
cases:9.48%
controls:2.34%
cases:5.04%
controls:0.91%
cases:1.63%
controls:0.40%
cases:3.60%
controls:1.00%
cases:11.79%
controls:2.92%
cases:22.43%
controls:8.38%
61
252
612
6439
64
157
611
6549
34
61
641
6645
11
27
664
6679
24
67
642
6628
73
191
546
6355
120
479
415
5238
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 [3019473]
2.7e+00
3.7e+00
1.0e+50
1.0e+50
1.0e+50
—
3.2e+00
cases:3.71%
controls:0.27%
cases:5.19%
controls:0.13%
cases:1.48%
controls:0.00%
cases:2.67%
controls:0.00%
cases:9.31%
controls:0.00%
—
—
cases:6.54%
controls:0.30%
25
18
648
6673
35
9
640
6697
10
0
665
6706
18
0
657
6706
62
0
604
6695
—
35
17
500
5700
Epilepsy
G40 [45595935]
2.0e+00
2.3e+00
—
—
—
2.7e+00
2.5e+00
cases:1.93%
controls:0.27%
cases:1.04%
controls:0.10%
—
—
—
—
—
—
cases:1.62%
controls:0.11%
cases:2.62%
controls:0.23%
13
18
660
6673
7
7
668
6699
—
—
—
10
7
609
6539
14
13
521
5704
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
7.6e-01
1.7e+00
2.3e+00
—
2.6e+00
1.3e+00
7.9e-01
cases:7.88%
controls:3.84%
cases:9.04%
controls:1.74%
cases:2.37%
controls:0.25%
—
—
cases:2.40%
controls:0.18%
cases:5.65%
controls:1.67%
cases:13.08%
controls:6.42%
53
257
620
6434
61
117
614
6589
16
17
659
6689
—
16
12
650
6683
35
109
584
6437
70
367
465
5350
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5.4e-01
1.4e+00
2.8e+00
—
2.9e+00
1.5e+00
7.1e-01
cases:6.09%
controls:3.63%
cases:7.11%
controls:1.80%
cases:3.41%
controls:0.21%
—
—
cases:5.56%
controls:0.33%
cases:7.59%
controls:1.73%
cases:8.60%
controls:4.41%
41
243
632
6448
48
121
627
6585
23
14
652
6692
—
37
22
629
6673
47
113
572
6433
46
252
489
5465
Cell count panel - Cerebral spinal fluid
34563-7 [3044290]
2.3e+00
3.7e+00
1.0e+50
1.0e+50
1.0e+50
—
3.4e+00
cases:2.38%
controls:0.25%
cases:5.04%
controls:0.13%
cases:1.04%
controls:0.00%
cases:1.78%
controls:0.00%
cases:7.81%
controls:0.00%
—
—
cases:5.23%
controls:0.17%
16
17
657
6674
34
9
641
6697
7
0
668
6706
12
0
663
6706
52
0
614
6695
—
28
10
507
5707
Bacteria identified in Blood by Culture
600-7 [3023368]
8.5e-01
1.4e+00
2.2e+00
—
3.4e+00
9.1e-01
5.7e-01
cases:7.43%
controls:3.32%
cases:5.63%
controls:1.39%
cases:2.67%
controls:0.30%
—
—
cases:5.11%
controls:0.18%
cases:3.88%
controls:1.60%
cases:8.97%
controls:5.30%
50
222
623
6469
38
93
637
6613
18
20
657
6686
—
34
12
632
6683
24
105
595
6441
48
303
487
5414
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
7.0e-02
6.4e-01
1.8e+00
4.2e+00
2.1e+00
6.3e-01
2.6e-01
cases:23.92%
controls:22.67%
cases:23.85%
controls:14.17%
cases:13.78%
controls:2.56%
cases:14.22%
controls:0.25%
cases:19.82%
controls:3.00%
cases:24.39%
controls:14.70%
cases:37.76%
controls:31.92%
161
1517
512
5174
161
950
514
5756
93
172
582
6534
96
17
579
6689
132
201
534
6494
151
962
468
5584
202
1825
333
3892
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.9e-01
1.0e+00
1.8e+00
3.3e+00
1.9e+00
7.0e-01
5.3e-01
cases:11.00%
controls:7.74%
cases:10.67%
controls:4.16%
cases:3.85%
controls:0.64%
cases:2.07%
controls:0.07%
cases:5.11%
controls:0.79%
cases:9.05%
controls:4.72%
cases:21.87%
controls:14.19%
74
518
599
6173
72
279
603
6427
26
43
649
6663
14
5
661
6701
34
53
632
6642
56
309
563
6237
117
811
418
4906
Psychiatry
26 [38004469]
1.2e+00
1.5e+00
1.5e+00
—
2.1e+00
1.6e+00
1.4e+00
cases:11.89%
controls:3.86%
cases:7.85%
controls:1.80%
cases:3.11%
controls:0.69%
—
—
cases:4.80%
controls:0.64%
cases:8.72%
controls:1.94%
cases:14.02%
controls:3.94%
80
258
593
6433
53
121
622
6585
21
46
654
6660
—
32
43
634
6652
54
127
565
6419
75
225
460
5492
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.9e-01
9.5e-01
1.8e+00
3.3e+00
1.9e+00
6.9e-01
5.2e-01
cases:10.85%
controls:7.61%
cases:10.07%
controls:4.15%
cases:3.85%
controls:0.64%
cases:2.07%
controls:0.07%
cases:5.11%
controls:0.76%
cases:8.89%
controls:4.64%
cases:21.50%
controls:13.94%
73
509
600
6182
68
278
607
6428
26
43
649
6663
14
5
661
6701
34
51
632
6644
55
304
564
6242
115
797
420
4920
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.7e-01
9.8e-01
1.8e+00
3.3e+00
1.9e+00
6.6e-01
5.5e-01
cases:11.00%
controls:7.83%
cases:10.52%
controls:4.24%
cases:3.85%
controls:0.66%
cases:2.07%
controls:0.07%
cases:5.11%
controls:0.78%
cases:8.89%
controls:4.78%
cases:22.24%
controls:14.13%
74
524
599
6167
71
284
604
6422
26
44
649
6662
14
5
661
6701
34
52
632
6643
55
313
564
6233
119
808
416
4909
Emergency Room and Inpatient Visit
ERIP [262]
8.0e-01
1.4e+00
2.0e+00
—
3.0e+00
1.2e+00
5.9e-01
cases:6.54%
controls:3.05%
cases:8.00%
controls:2.03%
cases:3.11%
controls:0.43%
—
—
cases:4.80%
controls:0.24%
cases:6.62%
controls:2.05%
cases:11.59%
controls:6.75%
44
204
629
6487
54
136
621
6570
21
29
654
6677
—
32
16
634
6679
41
134
578
6412
62
386
473
5331
Emergency Room Visit
ER [9203]
5.1e-01
1.3e+00
2.5e+00
—
2.6e+00
1.3e+00
8.9e-01
cases:44.43%
controls:32.42%
cases:33.63%
controls:12.27%
cases:17.48%
controls:1.73%
—
—
cases:16.67%
controls:1.49%
cases:32.47%
controls:11.87%
cases:54.77%
controls:33.25%
299
2169
374
4522
227
823
448
5883
118
116
557
6590
—
111
100
555
6595
201
777
418
5769
293
1901
242
3816
Limited function/disability NOS
A28 [2002000162]
8.7e-01
1.6e+00
1.9e+00
—
1.7e+00
1.6e+00
1.3e+00
cases:3.71%
controls:1.58%
cases:4.59%
controls:1.00%
cases:2.81%
controls:0.43%
—
—
cases:2.25%
controls:0.42%
cases:5.33%
controls:1.16%
cases:11.59%
controls:3.50%
25
106
648
6585
31
67
644
6639
19
29
656
6677
—
15
28
651
6667
33
76
586
6470
62
200
473
5517
Epilepsy, unspecified
G40.9 [45562083]
2.0e+00
1.9e+00
—
—
—
2.5e+00
2.5e+00
cases:2.23%
controls:0.30%
cases:1.04%
controls:0.15%
—
—
—
—
—
—
cases:2.26%
controls:0.20%
cases:4.11%
controls:0.37%
15
20
658
6671
7
10
668
6696
—
—
—
14
13
605
6533
22
21
513
5696
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.0e+00
1.1e+00
2.5e+00
1.0e+50
3.0e+00
1.1e+00
5.8e-01
cases:3.42%
controls:1.24%
cases:2.37%
controls:0.79%
cases:1.48%
controls:0.12%
cases:1.78%
controls:0.00%
cases:1.80%
controls:0.09%
cases:2.58%
controls:0.89%
cases:5.42%
controls:3.11%
23
83
650
6608
16
53
659
6653
10
8
665
6698
12
0
663
6706
12
6
654
6689
16
58
603
6488
29
178
506
5539
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
7.0e-01
1.7e+00
2.5e+00
1.0e+50
2.2e+00
1.4e+00
1.0e+00
cases:3.27%
controls:1.64%
cases:4.44%
controls:0.81%
cases:1.78%
controls:0.15%
cases:1.93%
controls:0.00%
cases:0.90%
controls:0.10%
cases:2.58%
controls:0.67%
cases:6.36%
controls:2.40%
22
110
651
6581
30
54
645
6652
12
10
663
6696
13
0
662
6706
6
7
660
6688
16
44
603
6502
34
137
501
5580
Essential (primary) hypertension
I10 [45591453]
1.8e-01
6.4e-01
1.1e+00
4.6e+00
1.7e+00
6.9e-01
1.2e-01
cases:18.42%
controls:15.93%
cases:14.81%
controls:8.37%
cases:4.00%
controls:1.43%
cases:6.81%
controls:0.07%
cases:8.11%
controls:1.63%
cases:16.16%
controls:8.85%
cases:25.79%
controls:23.61%
124
1066
549
5625
100
561
575
6145
27
96
648
6610
46
5
629
6701
54
109
612
6586
100
579
519
5967
138
1350
397
4367
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.7e-01
4.6e-01
1.6e+00
4.1e+00
1.9e+00
5.1e-01
2.4e-01
cases:28.68%
controls:25.32%
cases:28.59%
controls:20.10%
cases:15.11%
controls:3.37%
cases:14.81%
controls:0.30%
cases:20.72%
controls:3.67%
cases:29.89%
controls:20.35%
cases:43.18%
controls:37.38%
193
1694
480
4997
193
1348
482
5358
102
226
573
6480
100
20
575
6686
138
246
528
6449
185
1332
434
5214
231
2137
304
3580
Headache
R51.80 [2000503603]
1.5e+00
2.5e+00
—
1.0e+50
—
2.6e+00
2.0e+00
cases:5.79%
controls:1.32%
cases:5.48%
controls:0.48%
—
—
cases:1.93%
controls:0.00%
—
—
cases:4.20%
controls:0.34%
cases:10.28%
controls:1.52%
39
88
634
6603
37
32
638
6674
—
13
0
662
6706
—
26
22
593
6524
55
87
480
5630
Lumbar puncture
TAB00 [2001300538]
1.1e+00
3.2e+00
—
—
—
2.9e+00
2.5e+00
cases:1.34%
controls:0.46%
cases:2.22%
controls:0.09%
—
—
—
—
—
—
cases:1.62%
controls:0.09%
cases:2.80%
controls:0.24%
9
31
664
6660
15
6
660
6700
—
—
—
10
6
609
6540
15
14
520
5703
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.5e-01
4.6e-01
1.6e+00
4.1e+00
1.9e+00
5.1e-01
2.2e-01
cases:28.53%
controls:25.50%
cases:28.89%
controls:20.35%
cases:15.11%
controls:3.43%
cases:14.81%
controls:0.30%
cases:20.72%
controls:3.75%
cases:30.05%
controls:20.55%
cases:42.99%
controls:37.62%
192
1706
481
4985
195
1365
480
5341
102
230
573
6476
100
20
575
6686
138
251
528
6444
186
1345
433
5201
230
2151
305
3566
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
5.8e-01
1.1e+00
2.4e+00
—
2.8e+00
1.5e+00
7.1e-01
cases:5.20%
controls:2.97%
cases:4.15%
controls:1.39%
cases:2.22%
controls:0.21%
—
—
cases:3.15%
controls:0.19%
cases:5.33%
controls:1.28%
cases:5.98%
controls:3.04%
35
199
638
6492
28
93
647
6613
15
14
660
6692
—
21
13
645
6682
33
84
586
6462
32
174
503
5543
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
2.4e+00
3.4e+00
1.0e+50
1.0e+50
1.0e+50
—
2.7e+00
cases:2.53%
controls:0.24%
cases:3.70%
controls:0.13%
cases:1.48%
controls:0.00%
cases:2.07%
controls:0.00%
cases:5.41%
controls:0.00%
—
—
cases:4.67%
controls:0.31%
17
16
656
6675
25
9
650
6697
10
0
665
6706
14
0
661
6706
36
0
630
6695
—
25
18
510
5699
Urgent procedure
ZXD05 [2001311386]
6.2e-01
1.7e+00
3.4e+00
1.0e+50
—
1.4e+00
1.3e+00
cases:6.39%
controls:3.53%
cases:5.93%
controls:1.15%
cases:3.41%
controls:0.12%
cases:7.56%
controls:0.00%
—
—
cases:4.20%
controls:1.04%
cases:12.52%
controls:3.64%
43
236
630
6455
40
77
635
6629
23
8
652
6698
51
0
624
6706
—
26
68
593
6478
67
208
468
5509
CBC panel - Blood by Automated count
58410-2 [40761511]
5.2e-02
4.6e-01
1.6e+00
3.9e+00
1.9e+00
5.1e-01
2.3e-01
cases:26.00%
controls:25.02%
cases:24.44%
controls:16.90%
cases:12.30%
controls:2.77%
cases:11.26%
controls:0.25%
cases:16.67%
controls:2.97%
cases:25.36%
controls:16.91%
cases:39.07%
controls:33.85%
175
1674
498
5017
165
1133
510
5573
83
186
592
6520
76
17
599
6689
111
199
555
6496
157
1107
462
5439
209
1935
326
3782
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.5e-01
1.3e+00
2.2e+00
—
2.7e+00
1.2e+00
5.3e-01
cases:13.52%
controls:9.04%
cases:14.37%
controls:4.44%
cases:6.81%
controls:0.84%
—
—
cases:9.31%
controls:0.66%
cases:12.76%
controls:4.28%
cases:21.12%
controls:13.64%
91
605
582
6086
97
298
578
6408
46
56
629
6650
—
62
44
604
6651
79
280
540
6266
113
780
422
4937
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
2.0e+00
—
—
—
1.0e+50
3.1e+00
3.3e+00
cases:1.19%
controls:0.16%
—
—
—
—
—
—
cases:0.90%
controls:0.00%
cases:1.62%
controls:0.08%
cases:3.18%
controls:0.12%
8
11
665
6680
—
—
—
6
0
660
6695
10
5
609
6541
17
7
518
5710
Acute tubulo-interstitial nephritis
N10 [45543856]
6.3e-01
1.7e+00
2.3e+00
—
2.3e+00
1.7e+00
6.0e-01
cases:2.38%
controls:1.29%
cases:2.37%
controls:0.46%
cases:1.04%
controls:0.10%
—
—
cases:0.90%
controls:0.09%
cases:2.10%
controls:0.38%
cases:4.49%
controls:2.52%
16
86
657
6605
16
31
659
6675
7
7
668
6699
—
6
6
660
6689
13
25
606
6521
24
144
511
5573
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
4.8e-01
1.2e+00
2.2e+00
—
2.7e+00
8.2e-01
5.2e-01
cases:10.85%
controls:7.02%
cases:11.70%
controls:3.92%
cases:5.19%
controls:0.60%
—
—
cases:6.91%
controls:0.48%
cases:8.08%
controls:3.71%
cases:16.64%
controls:10.62%
73
470
600
6221
79
263
596
6443
35
40
640
6666
—
46
32
620
6663
50
243
569
6303
89
607
446
5110
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
2.6e-01
7.0e-01
1.2e+00
3.6e+00
1.9e+00
4.9e-01
2.2e-01
cases:15.16%
controls:12.08%
cases:11.70%
controls:6.20%
cases:3.41%
controls:1.07%
cases:2.67%
controls:0.07%
cases:7.06%
controls:1.09%
cases:10.34%
controls:6.58%
cases:21.12%
controls:17.70%
102
808
571
5883
79
416
596
6290
23
72
652
6634
18
5
657
6701
47
73
619
6622
64
431
555
6115
113
1012
422
4705
Functional capacity evaluation
443351003 [40481051]
8.2e-01
1.8e+00
2.3e+00
—
1.6e+00
1.5e+00
1.3e+00
cases:3.57%
controls:1.60%
cases:3.56%
controls:0.60%
cases:1.48%
controls:0.15%
—
—
cases:1.05%
controls:0.21%
cases:4.04%
controls:0.90%
cases:9.16%
controls:2.66%
24
107
649
6584
24
40
651
6666
10
10
665
6696
—
7
14
659
6681
25
59
594
6487
49
152
486
5565
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
5.4e-02
3.9e-01
1.5e+00
3.8e+00
1.7e+00
4.0e-01
1.5e-01
cases:28.38%
controls:27.31%
cases:30.22%
controls:22.64%
cases:17.04%
controls:4.49%
cases:14.37%
controls:0.39%
cases:20.72%
controls:4.68%
cases:31.18%
controls:23.24%
cases:44.11%
controls:40.39%
191
1827
482
4864
204
1518
471
5188
115
301
560
6405
97
26
578
6680
138
313
528
6382
193
1521
426
5025
236
2309
299
3408
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
4.1e-02
3.5e-01
1.5e+00
3.9e+00
1.6e+00
4.1e-01
4.3e-02
cases:22.44%
controls:21.73%
cases:22.37%
controls:16.85%
cases:11.85%
controls:3.03%
cases:10.67%
controls:0.24%
cases:15.02%
controls:3.54%
cases:23.75%
controls:17.09%
cases:32.71%
controls:31.76%
151
1454
522
5237
151
1130
524
5576
80
203
595
6503
72
16
603
6690
100
237
566
6458
147
1119
472
5427
175
1816
360
3901
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
5.5e-01
1.1e+00
2.2e+00
—
2.1e+00
9.7e-01
7.0e-01
cases:7.88%
controls:4.69%
cases:6.96%
controls:2.33%
cases:2.81%
controls:0.33%
—
—
cases:3.45%
controls:0.43%
cases:7.11%
controls:2.81%
cases:14.95%
controls:8.03%
53
314
620
6377
47
156
628
6550
19
22
656
6684
—
23
29
643
6666
44
184
575
6362
80
459
455
5258
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.8e+00
1.6e+00
—
—
—
2.5e+00
1.8e+00
cases:2.53%
controls:0.42%
cases:1.33%
controls:0.28%
—
—
—
—
—
—
cases:2.10%
controls:0.18%
cases:3.18%
controls:0.54%
17
28
656
6663
9
19
666
6687
—
—
—
13
12
606
6534
17
31
518
5686
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
5.0e-01
1.4e+00
2.1e+00
—
3.3e+00
7.8e-01
7.5e-01
cases:3.27%
controls:2.02%
cases:4.44%
controls:1.12%
cases:1.19%
controls:0.15%
—
—
cases:3.45%
controls:0.13%
cases:1.94%
controls:0.90%
cases:5.61%
controls:2.73%
22
135
651
6556
30
75
645
6631
8
10
667
6696
—
23
9
643
6686
12
59
607
6487
30
156
505
5561
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.0e+00
1.9e+00
—
—
2.5e+00
1.2e+00
8.7e-01
cases:3.27%
controls:1.23%
cases:5.04%
controls:0.76%
—
—
—
—
cases:0.90%
controls:0.07%
cases:2.10%
controls:0.66%
cases:5.42%
controls:2.34%
22
82
651
6609
34
51
641
6655
—
—
6
5
660
6690
13
43
606
6503
29
134
506
5583
Platelets [#/volume] in Blood
26515-7 [3007461]
9.8e-03
3.7e-01
1.3e+00
3.8e+00
1.6e+00
3.4e-01
9.4e-02
cases:29.42%
controls:29.22%
cases:31.70%
controls:24.32%
cases:16.59%
controls:5.01%
cases:14.81%
controls:0.39%
cases:21.32%
controls:5.35%
cases:32.47%
controls:25.47%
cases:45.23%
controls:42.91%
198
1955
475
4736
214
1631
461
5075
112
336
563
6370
100
26
575
6680
142
358
524
6337
201
1667
418
4879
242
2453
293
3264
MCH [Entitic mass]
28539-5 [3035941]
1.3e-02
3.6e-01
1.3e+00
3.8e+00
1.6e+00
3.4e-01
8.6e-02
cases:29.57%
controls:29.29%
cases:31.70%
controls:24.41%
cases:16.59%
controls:5.01%
cases:14.81%
controls:0.39%
cases:21.32%
controls:5.39%
cases:32.47%
controls:25.50%
cases:45.05%
controls:42.92%
199
1960
474
4731
214
1637
461
5069
112
336
563
6370
100
26
575
6680
142
361
524
6334
201
1669
418
4877
241
2454
294
3263
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
9.7e-03
3.6e-01
1.3e+00
3.8e+00
1.6e+00
3.4e-01
8.3e-02
cases:29.57%
controls:29.37%
cases:31.70%
controls:24.44%
cases:16.59%
controls:5.01%
cases:14.81%
controls:0.40%
cases:21.47%
controls:5.39%
cases:32.47%
controls:25.48%
cases:45.05%
controls:42.99%
199
1965
474
4726
214
1639
461
5067
112
336
563
6370
100
27
575
6679
143
361
523
6334
201
1668
418
4878
241
2458
294
3259
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.0e-02
3.6e-01
1.3e+00
3.8e+00
1.6e+00
3.4e-01
9.1e-02
cases:29.57%
controls:29.35%
cases:31.70%
controls:24.41%
cases:16.59%
controls:5.01%
cases:14.81%
controls:0.40%
cases:21.32%
controls:5.39%
cases:32.47%
controls:25.53%
cases:45.23%
controls:42.99%
199
1964
474
4727
214
1637
461
5069
112
336
563
6370
100
27
575
6679
142
361
524
6334
201
1671
418
4875
242
2458
293
3259
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.1e-02
3.6e-01
1.3e+00
3.8e+00
1.6e+00
3.4e-01
9.1e-02
cases:29.57%
controls:29.34%
cases:31.70%
controls:24.44%
cases:16.59%
controls:5.01%
cases:14.81%
controls:0.40%
cases:21.32%
controls:5.39%
cases:32.47%
controls:25.54%
cases:45.23%
controls:42.99%
199
1963
474
4728
214
1639
461
5067
112
336
563
6370
100
27
575
6679
142
361
524
6334
201
1672
418
4874
242
2458
293
3259
Leukocytes [#/volume] in Blood
26464-8 [3010813]
8.2e-03
3.6e-01
1.3e+00
3.8e+00
1.6e+00
3.4e-01
8.2e-02
cases:29.57%
controls:29.40%
cases:31.70%
controls:24.47%
cases:16.59%
controls:5.03%
cases:14.81%
controls:0.40%
cases:21.32%
controls:5.41%
cases:32.47%
controls:25.50%
cases:45.05%
controls:43.03%
199
1967
474
4724
214
1641
461
5065
112
337
563
6369
100
27
575
6679
142
362
524
6333
201
1669
418
4877
241
2460
294
3257
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
9.7e-03
3.6e-01
1.3e+00
3.8e+00
1.6e+00
3.3e-01
9.0e-02
cases:29.57%
controls:29.37%
cases:31.70%
controls:24.46%
cases:16.59%
controls:5.04%
cases:14.81%
controls:0.40%
cases:21.32%
controls:5.41%
cases:32.47%
controls:25.60%
cases:45.23%
controls:43.01%
199
1965
474
4726
214
1640
461
5066
112
338
563
6368
100
27
575
6679
142
362
524
6333
201
1676
418
4870
242
2459
293
3258
Examination of eyes and vision
Z01.0 [45566391]
4.0e-01
2.9e-01
2.6e+00
—
2.5e+00
1.6e+00
6.9e-01
cases:3.42%
controls:2.32%
cases:1.04%
controls:0.78%
cases:1.19%
controls:0.09%
—
—
cases:1.20%
controls:0.10%
cases:3.23%
controls:0.69%
cases:5.98%
controls:3.10%
23
155
650
6536
7
52
668
6654
8
6
667
6700
—
8
7
658
6688
20
45
599
6501
32
177
503
5540
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.1e-01
1.0e+00
2.0e+00
—
2.9e+00
1.3e+00
4.7e-01
cases:3.12%
controls:2.79%
cases:4.00%
controls:1.45%
cases:1.19%
controls:0.16%
—
—
cases:3.60%
controls:0.21%
cases:4.68%
controls:1.30%
cases:5.61%
controls:3.57%
21
187
652
6504
27
97
648
6609
8
11
667
6695
—
24
14
642
6681
29
85
590
6461
30
204
505
5513
Intravenous general anesthesia
WX404 [2001310807]
1.6e-01
1.3e+00
—
1.0e+50
2.6e+00
1.9e+00
1.5e+00
cases:2.82%
controls:2.42%
cases:2.52%
controls:0.72%
—
—
cases:2.07%
controls:0.00%
cases:1.20%
controls:0.09%
cases:2.75%
controls:0.43%
cases:5.05%
controls:1.22%
19
162
654
6529
17
48
658
6658
—
14
0
661
6706
8
6
658
6689
17
28
602
6518
27
70
508
5647
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.0e-01
1.1e+00
2.2e+00
—
2.7e+00
1.1e+00
3.7e-01
cases:7.73%
controls:5.86%
cases:8.00%
controls:2.70%
cases:2.96%
controls:0.33%
—
—
cases:5.86%
controls:0.42%
cases:7.92%
controls:2.67%
cases:11.03%
controls:7.87%
52
392
621
6299
54
181
621
6525
20
22
655
6684
—
39
28
627
6667
49
175
570
6371
59
450
476
5267
Right side
ZXA00 [2001311346]
5.6e-01
9.7e-01
2.0e+00
1.0e+50
2.5e+00
1.7e+00
6.3e-01
cases:5.79%
controls:3.41%
cases:2.37%
controls:0.91%
cases:0.89%
controls:0.12%
cases:1.04%
controls:0.00%
cases:1.65%
controls:0.13%
cases:4.68%
controls:0.93%
cases:6.17%
controls:3.39%
39
228
634
6463
16
61
659
6645
6
8
669
6698
7
0
668
6706
11
9
655
6686
29
61
590
6485
33
194
502
5523
Psychologist
Z2445 [2001311558]
1.1e+00
2.3e+00
—
—
—
3.0e+00
1.9e+00
cases:1.04%
controls:0.34%
cases:0.89%
controls:0.09%
—
—
—
—
—
—
cases:2.10%
controls:0.11%
cases:1.87%
controls:0.30%
7
23
666
6668
6
6
669
6700
—
—
—
13
7
606
6539
10
17
525
5700
Sequelae of subarachnoid haemorrhage
I69.0 [45543193]
2.9e+00
—
—
1.0e+50
—
—
4.2e+00
cases:1.63%
controls:0.09%
—
—
—
—
cases:1.19%
controls:0.00%
—
—
—
—
cases:6.73%
controls:0.10%
11
6
662
6685
—
—
8
0
667
6706
—
—
36
6
499
5711
Laceration/cut
S18 [2002000983]
5.5e-01
1.0e+00
1.9e+00
—
2.5e+00
1.2e+00
4.4e-01
cases:9.36%
controls:5.65%
cases:5.63%
controls:2.10%
cases:1.93%
controls:0.30%
—
—
cases:3.60%
controls:0.31%
cases:7.75%
controls:2.49%
cases:12.52%
controls:8.41%
63
378
610
6313
38
141
637
6565
13
20
662
6686
—
24
21
642
6674
48
163
571
6383
67
481
468
5236
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.9e-01
8.2e-01
1.7e+00
2.7e+00
1.8e+00
4.7e-01
3.3e-01
cases:10.40%
controls:7.98%
cases:9.33%
controls:4.35%
cases:4.00%
controls:0.73%
cases:1.33%
controls:0.09%
cases:5.56%
controls:0.93%
cases:6.14%
controls:3.91%
cases:15.51%
controls:11.68%
70
534
603
6157
63
292
612
6414
27
49
648
6657
9
6
666
6700
37
62
629
6633
38
256
581
6290
83
668
452
5049
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
3.9e-01
1.1e+00
2.1e+00
—
2.5e+00
8.4e-01
4.3e-01
cases:11.14%
controls:7.82%
cases:12.74%
controls:4.49%
cases:5.63%
controls:0.70%
—
—
cases:6.91%
controls:0.58%
cases:9.37%
controls:4.26%
cases:17.94%
controls:12.47%
75
523
598
6168
86
301
589
6405
38
47
637
6659
—
46
39
620
6656
58
279
561
6267
96
713
439
5004
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
1.6e-01
1.0e+00
1.9e+00
—
3.0e+00
1.2e+00
5.5e-01
cases:4.75%
controls:4.10%
cases:5.48%
controls:2.01%
cases:1.33%
controls:0.21%
—
—
cases:4.20%
controls:0.22%
cases:5.33%
controls:1.67%
cases:8.22%
controls:4.93%
32
274
641
6417
37
135
638
6571
9
14
666
6692
—
28
15
638
6680
33
109
586
6437
44
282
491
5435
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
7.0e-01
1.2e+00
1.9e+00
—
2.3e+00
1.0e+00
5.1e-01
cases:6.09%
controls:3.12%
cases:5.93%
controls:1.92%
cases:2.07%
controls:0.31%
—
—
cases:3.15%
controls:0.33%
cases:5.49%
controls:2.08%
cases:9.91%
controls:6.17%
41
209
632
6482
40
129
635
6577
14
21
661
6685
—
21
22
645
6673
34
136
585
6410
53
353
482
5364
tolterodine; oral
G04BD07 [21602640]
1.7e+00
1.8e+00
2.0e+00
—
—
1.9e+00
1.6e+00
cases:4.01%
controls:0.73%
cases:2.07%
controls:0.34%
cases:0.74%
controls:0.10%
—
—
—
—
cases:2.26%
controls:0.35%
cases:3.93%
controls:0.79%
27
49
646
6642
14
23
661
6683
5
7
670
6699
—
—
14
23
605
6523
21
45
514
5672
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
7.1e-01
1.9e+00
2.9e+00
—
—
1.5e+00
7.6e-01
cases:2.82%
controls:1.40%
cases:4.15%
controls:0.67%
cases:1.63%
controls:0.09%
—
—
—
—
cases:3.07%
controls:0.69%
cases:5.61%
controls:2.71%
19
94
654
6597
28
45
647
6661
11
6
664
6700
—
—
19
45
600
6501
30
155
505
5562
Bacteria identified in Urine by Culture
630-4 [3026008]
4.9e-01
1.1e+00
1.7e+00
—
2.5e+00
1.1e+00
6.9e-01
cases:6.54%
controls:4.11%
cases:5.93%
controls:2.10%
cases:2.07%
controls:0.40%
—
—
cases:5.11%
controls:0.45%
cases:6.62%
controls:2.35%
cases:13.64%
controls:7.31%
44
275
629
6416
40
141
635
6565
14
27
661
6679
—
34
30
632
6665
41
154
578
6392
73
418
462
5299
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.5e-01
9.8e-01
2.1e+00
—
2.2e+00
9.8e-01
6.8e-01
cases:6.98%
controls:5.04%
cases:6.52%
controls:2.55%
cases:2.67%
controls:0.33%
—
—
cases:4.05%
controls:0.46%
cases:6.79%
controls:2.66%
cases:14.58%
controls:7.94%
47
337
626
6354
44
171
631
6535
18
22
657
6684
—
27
31
639
6664
42
174
577
6372
78
454
457
5263
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
6.7e-01
1.2e+00
—
1.0e+50
3.3e+00
1.6e+00
8.2e-01
cases:2.82%
controls:1.46%
cases:2.07%
controls:0.61%
—
—
cases:1.33%
controls:0.00%
cases:2.40%
controls:0.09%
cases:3.23%
controls:0.67%
cases:4.49%
controls:2.03%
19
98
654
6593
14
41
661
6665
—
9
0
666
6706
16
6
650
6689
20
44
599
6502
24
116
511
5601
Cathetrisation of vein
TPH04 [2001309597]
1.6e-01
1.4e+00
2.5e+00
1.0e+50
2.1e+00
9.1e-01
9.9e-01
cases:3.12%
controls:2.68%
cases:2.96%
controls:0.72%
cases:1.04%
controls:0.09%
cases:1.33%
controls:0.00%
cases:1.05%
controls:0.13%
cases:2.10%
controls:0.86%
cases:6.92%
controls:2.68%
21
179
652
6512
20
48
655
6658
7
6
668
6700
9
0
666
6706
7
9
659
6686
13
56
606
6490
37
153
498
5564
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1.6e+00
2.3e+00
—
—
1.0e+50
1.9e+00
1.1e+00
cases:3.27%
controls:0.66%
cases:3.11%
controls:0.31%
—
—
—
—
cases:3.15%
controls:0.00%
cases:1.94%
controls:0.31%
cases:4.30%
controls:1.42%
22
44
651
6647
21
21
654
6685
—
—
21
0
645
6695
12
20
607
6526
23
81
512
5636
Specific gravity of Urine by Refractometry
5810-7 [3019150]
6.8e-01
1.1e+00
1.7e+00
—
1.9e+00
9.3e-01
6.0e-01
cases:7.13%
controls:3.75%
cases:5.63%
controls:1.91%
cases:1.78%
controls:0.34%
—
—
cases:2.40%
controls:0.36%
cases:5.65%
controls:2.31%
cases:11.96%
controls:6.93%
48
251
625
6440
38
128
637
6578
12
23
663
6683
—
16
24
650
6671
35
151
584
6395
64
396
471
5321
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.2e+00
2.0e+00
2.3e+00
—
—
2.5e+00
1.3e+00
cases:2.53%
controls:0.81%
cases:1.93%
controls:0.27%
cases:0.74%
controls:0.07%
—
—
—
—
cases:3.23%
controls:0.27%
cases:3.18%
controls:0.93%
17
54
656
6637
13
18
662
6688
5
5
670
6701
—
—
20
18
599
6528
17
53
518
5664
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.1e+00
2.4e+00
—
—
—
2.2e+00
1.2e+00
cases:2.38%
controls:0.81%
cases:1.93%
controls:0.18%
—
—
—
—
—
—
cases:2.10%
controls:0.23%
cases:2.80%
controls:0.89%
16
54
657
6637
13
12
662
6694
—
—
—
13
15
606
6531
15
51
520
5666
Emergency Medicine
93 [38004510]
4.0e-01
1.1e+00
2.2e+00
—
2.1e+00
7.0e-01
4.3e-01
cases:13.97%
controls:9.85%
cases:14.67%
controls:5.29%
cases:6.37%
controls:0.76%
—
—
cases:5.26%
controls:0.70%
cases:11.47%
controls:6.06%
cases:24.11%
controls:17.18%
94
659
579
6032
99
355
576
6351
43
51
632
6655
—
35
47
631
6648
71
397
548
6149
129
982
406
4735
Body temperature
8310-5 [3020891]
1.3e+00
2.2e+00
—
—
1.0e+50
2.0e+00
1.3e+00
cases:1.63%
controls:0.43%
cases:2.07%
controls:0.24%
—
—
—
—
cases:1.35%
controls:0.00%
cases:1.13%
controls:0.15%
cases:3.74%
controls:1.00%
11
29
662
6662
14
16
661
6690
—
—
9
0
657
6695
7
10
612
6536
20
57
515
5660
Sequelae of cerebral infarction
I69.3 [45533476]
3.9e-01
1.2e+00
1.7e+00
—
2.9e+00
1.8e+00
9.6e-01
cases:1.34%
controls:0.91%
cases:1.93%
controls:0.58%
cases:0.74%
controls:0.13%
—
—
cases:1.35%
controls:0.07%
cases:2.91%
controls:0.50%
cases:4.30%
controls:1.70%
9
61
664
6630
13
39
662
6667
5
9
670
6697
—
9
5
657
6690
18
33
601
6513
23
97
512
5620
Supplier / Service Provider
OMOP5117446 [33004]
-8.7e-01
-9.3e-02
3.5e-01
—
2.9e+00
2.4e+00
2.3e+00
cases:13.08%
controls:26.38%
cases:6.37%
controls:6.95%
cases:0.89%
controls:0.63%
—
—
cases:1.35%
controls:0.07%
cases:5.17%
controls:0.47%
cases:8.97%
controls:0.98%
88
1765
585
4926
43
466
632
6240
6
42
669
6664
—
9
5
657
6690
32
31
587
6515
48
56
487
5661
Cerebral infarction, unspecified
I63.9 [45596216]
1.2e-01
1.3e+00
—
1.0e+50
3.1e+00
1.4e+00
9.3e-01
cases:1.49%
controls:1.32%
cases:2.07%
controls:0.57%
—
—
cases:1.78%
controls:0.00%
cases:1.65%
controls:0.07%
cases:1.94%
controls:0.49%
cases:5.23%
controls:2.13%
10
88
663
6603
14
38
661
6668
—
12
0
663
6706
11
5
655
6690
12
32
607
6514
28
122
507
5595
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.2e-02
2.7e-01
1.2e+00
3.9e+00
1.6e+00
2.5e-01
5.8e-02
cases:18.42%
controls:18.10%
cases:18.52%
controls:14.78%
cases:9.48%
controls:3.18%
cases:9.63%
controls:0.21%
cases:13.81%
controls:3.18%
cases:19.22%
controls:15.61%
cases:29.16%
controls:27.97%
124
1211
549
5480
125
991
550
5715
64
213
611
6493
65
14
610
6692
92
213
574
6482
119
1022
500
5524
156
1599
379
4118
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.3e+00
1.3e+00
2.6e+00
1.0e+50
—
1.5e+00
5.7e-01
cases:2.97%
controls:0.79%
cases:1.78%
controls:0.49%
cases:1.33%
controls:0.10%
cases:1.63%
controls:0.00%
—
—
cases:2.42%
controls:0.57%
cases:4.30%
controls:2.47%
20
53
653
6638
12
33
663
6673
9
7
666
6699
11
0
664
6706
—
15
37
604
6509
23
141
512
5576
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
—
2.4e+00
—
—
—
2.7e+00
1.6e+00
—
—
cases:1.48%
controls:0.13%
—
—
—
—
—
—
cases:1.94%
controls:0.14%
cases:1.87%
controls:0.38%
—
10
9
665
6697
—
—
—
12
9
607
6537
10
22
525
5695
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
1.5e+00
2.3e+00
—
—
1.0e+50
2.0e+00
9.3e-01
cases:3.71%
controls:0.87%
cases:4.30%
controls:0.46%
—
—
—
—
cases:4.05%
controls:0.00%
cases:2.91%
controls:0.41%
cases:4.86%
controls:1.98%
25
58
648
6633
29
31
646
6675
—
—
27
0
639
6695
18
27
601
6519
26
113
509
5604
Gas panel - Arterial blood
24336-0 [3019060]
1.6e+00
2.2e+00
—
—
1.0e+50
1.7e+00
1.2e+00
cases:3.12%
controls:0.66%
cases:2.96%
controls:0.34%
—
—
—
—
cases:3.00%
controls:0.00%
cases:1.78%
controls:0.32%
cases:3.55%
controls:1.14%
21
44
652
6647
20
23
655
6683
—
—
20
0
646
6695
11
21
608
6525
19
65
516
5652
dexamethasone; oral, parenteral
H02AB02 [21602730]
5.3e-01
1.5e+00
2.3e+00
—
2.9e+00
7.4e-01
1.6e-01
cases:4.01%
controls:2.41%
cases:3.26%
controls:0.76%
cases:1.63%
controls:0.16%
—
—
cases:1.80%
controls:0.10%
cases:1.62%
controls:0.78%
cases:2.99%
controls:2.57%
27
161
646
6530
22
51
653
6655
11
11
664
6695
—
12
7
654
6688
10
51
609
6495
16
147
519
5570
oxybutynin; oral, transdermal
G04BD04 [21602637]
1.5e+00
2.0e+00
—
—
—
1.6e+00
1.6e+00
cases:2.53%
controls:0.60%
cases:1.78%
controls:0.25%
—
—
—
—
—
—
cases:1.29%
controls:0.26%
cases:1.87%
controls:0.38%
17
40
656
6651
12
17
663
6689
—
—
—
8
17
611
6529
10
22
525
5695
olanzapine; oral, parenteral
N05AH03 [21604543]
1.5e+00
1.6e+00
2.0e+00
—
—
1.1e+00
1.5e+00
cases:3.12%
controls:0.72%
cases:2.81%
controls:0.57%
cases:1.19%
controls:0.16%
—
—
—
—
cases:1.78%
controls:0.60%
cases:3.55%
controls:0.84%
21
48
652
6643
19
38
656
6668
8
11
667
6695
—
—
11
39
608
6507
19
48
516
5669
oxycodone; oral, parenteral
N02AA05 [21604260]
6.2e-01
1.3e+00
2.0e+00
—
2.1e+00
1.2e+00
6.0e-01
cases:2.53%
controls:1.37%
cases:2.37%
controls:0.66%
cases:1.48%
controls:0.21%
—
—
cases:1.95%
controls:0.24%
cases:2.75%
controls:0.89%
cases:5.05%
controls:2.83%
17
92
656
6599
16
44
659
6662
10
14
665
6692
—
13
16
653
6679
17
58
602
6488
27
162
508
5555
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
-9.4e-02
2.4e-01
1.3e+00
3.7e+00
1.4e+00
1.7e-01
4.9e-02
cases:17.09%
controls:18.46%
cases:19.26%
controls:15.81%
cases:10.67%
controls:3.10%
cases:8.59%
controls:0.22%
cases:12.61%
controls:3.30%
cases:18.90%
controls:16.38%
cases:29.72%
controls:28.70%
115
1235
558
5456
130
1060
545
5646
72
208
603
6498
58
15
617
6691
84
221
582
6474
117
1072
502
5474
159
1641
376
4076
mirabegron; oral
G04BD12 [43534790]
9.7e-01
1.4e+00
1.0e+00
—
1.5e+00
1.4e+00
1.2e+00
cases:3.86%
controls:1.49%
cases:3.70%
controls:0.91%
cases:0.89%
controls:0.33%
—
—
cases:1.35%
controls:0.31%
cases:3.72%
controls:0.96%
cases:6.73%
controls:2.17%
26
100
647
6591
25
61
650
6645
6
22
669
6684
—
9
21
657
6674
23
63
596
6483
36
124
499
5593
Other specified urinary incontinence
N39.4 [45577525]
1.1e+00
2.3e+00
—
—
—
1.6e+00
1.5e+00
cases:2.97%
controls:1.05%
cases:2.52%
controls:0.27%
—
—
—
—
—
—
cases:2.42%
controls:0.50%
cases:4.67%
controls:1.10%
20
70
653
6621
17
18
658
6688
—
—
—
15
33
604
6513
25
63
510
5654
Bacteria [Presence] in Urine
87829-8 [36304419]
3.6e-01
9.8e-01
1.8e+00
—
2.1e+00
8.8e-01
5.6e-01
cases:5.05%
controls:3.57%
cases:4.59%
controls:1.77%
cases:1.63%
controls:0.27%
—
—
cases:2.85%
controls:0.34%
cases:4.36%
controls:1.86%
cases:9.53%
controls:5.70%
34
239
639
6452
31
119
644
6587
11
18
664
6688
—
19
23
647
6672
27
122
592
6424
51
326
484
5391
INR in Blood by Coagulation assay
34714-6 [3032080]
4.5e-01
1.1e+00
1.5e+00
—
1.8e+00
9.8e-01
6.1e-01
cases:11.00%
controls:7.28%
cases:11.70%
controls:4.32%
cases:6.22%
controls:1.52%
—
—
cases:8.41%
controls:1.57%
cases:10.99%
controls:4.45%
cases:18.88%
controls:11.19%
74
487
599
6204
79
290
596
6416
42
102
633
6604
—
56
105
610
6590
68
291
551
6255
101
640
434
5077
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
3.2e-01
8.7e-01
1.9e+00
—
2.2e+00
7.8e-01
5.1e-01
cases:5.79%
controls:4.29%
cases:5.48%
controls:2.37%
cases:2.22%
controls:0.34%
—
—
cases:3.45%
controls:0.39%
cases:5.17%
controls:2.43%
cases:11.96%
controls:7.52%
39
287
634
6404
37
159
638
6547
15
23
660
6683
—
23
26
643
6669
32
159
587
6387
64
430
471
5287
Oxygen saturation in Arterial blood
2708-6 [3016502]
1.4e+00
2.1e+00
—
—
1.0e+50
1.8e+00
9.3e-01
cases:3.71%
controls:0.97%
cases:4.15%
controls:0.52%
—
—
—
—
cases:4.20%
controls:0.00%
cases:3.07%
controls:0.50%
cases:5.42%
controls:2.20%
25
65
648
6626
28
35
647
6671
—
—
28
0
638
6695
19
33
600
6513
29
126
506
5591
Bacteria identified in Isolate by Culture
43409-2 [3042936]
2.1e-01
1.1e+00
1.6e+00
—
3.3e+00
1.7e+00
6.7e-01
cases:2.38%
controls:1.94%
cases:2.22%
controls:0.73%
cases:0.74%
controls:0.15%
—
—
cases:2.40%
controls:0.09%
cases:2.91%
controls:0.52%
cases:4.11%
controls:2.15%
16
130
657
6561
15
49
660
6657
5
10
670
6696
—
16
6
650
6689
18
34
601
6512
22
123
513
5594
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.5e-01
9.3e-01
1.6e+00
—
2.3e+00
8.5e-01
4.6e-01
cases:15.16%
controls:11.13%
cases:12.74%
controls:5.47%
cases:5.19%
controls:1.04%
—
—
cases:9.16%
controls:1.03%
cases:13.09%
controls:6.05%
cases:24.30%
controls:16.88%
102
745
571
5946
86
367
589
6339
35
70
640
6636
—
61
69
605
6626
81
396
538
6150
130
965
405
4752
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
1.3e+00
2.1e+00
—
—
1.0e+50
1.7e+00
9.6e-01
cases:4.16%
controls:1.18%
cases:4.59%
controls:0.57%
—
—
—
—
cases:4.65%
controls:0.00%
cases:3.39%
controls:0.64%
cases:5.79%
controls:2.31%
28
79
645
6612
31
38
644
6668
—
—
31
0
635
6695
21
42
598
6504
31
132
504
5585
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
1.3e+00
2.1e+00
—
—
1.0e+50
1.7e+00
9.6e-01
cases:4.16%
controls:1.18%
cases:4.59%
controls:0.57%
—
—
—
—
cases:4.65%
controls:0.00%
cases:3.39%
controls:0.64%
cases:5.79%
controls:2.31%
28
79
645
6612
31
38
644
6668
—
—
31
0
635
6695
21
42
598
6504
31
132
504
5585
pH of Arterial blood
2744-1 [3019977]
1.3e+00
2.1e+00
—
—
1.0e+50
1.7e+00
9.1e-01
cases:4.16%
controls:1.15%
cases:4.59%
controls:0.58%
—
—
—
—
cases:4.65%
controls:0.00%
cases:3.39%
controls:0.63%
cases:5.61%
controls:2.33%
28
77
645
6614
31
39
644
6667
—
—
31
0
635
6695
21
41
598
6505
30
133
505
5584
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
1.2e-01
4.8e-01
1.4e+00
2.8e+00
1.4e+00
2.8e-01
2.8e-01
cases:16.05%
controls:14.47%
cases:13.93%
controls:9.10%
cases:5.78%
controls:1.52%
cases:1.63%
controls:0.10%
cases:6.76%
controls:1.70%
cases:11.15%
controls:8.68%
cases:25.42%
controls:20.52%
108
968
565
5723
94
610
581
6096
39
102
636
6604
11
7
664
6699
45
114
621
6581
69
568
550
5978
136
1173
399
4544
Infectious Disease
44 [38004484]
2.5e-01
2.8e-01
2.5e+00
—
2.5e+00
1.1e+00
6.0e-01
cases:1.78%
controls:1.39%
cases:0.89%
controls:0.67%
cases:0.89%
controls:0.07%
—
—
cases:0.90%
controls:0.07%
cases:2.10%
controls:0.73%
cases:2.80%
controls:1.56%
12
93
661
6598
6
45
669
6661
6
5
669
6701
—
6
5
660
6690
13
48
606
6498
15
89
520
5628
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
3.7e-01
8.9e-01
2.0e+00
—
1.9e+00
7.5e-01
5.6e-01
cases:9.66%
controls:6.90%
cases:7.85%
controls:3.39%
cases:3.41%
controls:0.49%
—
—
cases:3.90%
controls:0.61%
cases:7.43%
controls:3.67%
cases:17.57%
controls:10.88%
65
462
608
6229
53
227
622
6479
23
33
652
6673
—
26
41
640
6654
46
240
573
6306
94
622
441
5095
Stroke/cerebrovascular accident
K90 [2002000617]
1.3e+00
2.2e+00
—
—
—
2.4e+00
1.5e+00
cases:0.89%
controls:0.25%
cases:1.19%
controls:0.13%
—
—
—
—
—
—
cases:1.78%
controls:0.17%
cases:2.43%
controls:0.58%
6
17
667
6674
8
9
667
6697
—
—
—
11
11
608
6535
13
33
522
5684
Leukocytes [#/volume] in Urine
30405-5 [3018095]
3.2e-01
8.7e-01
1.9e+00
—
2.1e+00
6.8e-01
4.8e-01
cases:6.54%
controls:4.84%
cases:6.22%
controls:2.70%
cases:2.37%
controls:0.37%
—
—
cases:3.75%
controls:0.48%
cases:5.65%
controls:2.93%
cases:13.46%
controls:8.80%
44
324
629
6367
42
181
633
6525
16
25
659
6681
—
25
32
641
6663
35
192
584
6354
72
503
463
5214
Chloride [Moles/volume] in Blood
2069-3 [3018572]
1.8e+00
—
—
1.0e+50
1.0e+50
2.5e+00
1.6e+00
cases:1.19%
controls:0.19%
—
—
—
—
cases:1.48%
controls:0.00%
cases:2.10%
controls:0.00%
cases:0.97%
controls:0.08%
cases:1.50%
controls:0.30%
8
13
665
6678
—
—
10
0
665
6706
14
0
652
6695
6
5
613
6541
8
17
527
5700
Anion gap in Blood by calculation
41276-7 [3039000]
1.8e+00
—
—
1.0e+50
1.0e+50
2.5e+00
1.6e+00
cases:1.19%
controls:0.19%
—
—
—
—
cases:1.48%
controls:0.00%
cases:2.10%
controls:0.00%
cases:0.97%
controls:0.08%
cases:1.50%
controls:0.30%
8
13
665
6678
—
—
10
0
665
6706
14
0
652
6695
6
5
613
6541
8
17
527
5700
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
5.1e-01
1.5e+00
2.1e+00
—
—
1.4e+00
9.6e-01
cases:3.42%
controls:2.08%
cases:2.81%
controls:0.66%
cases:0.89%
controls:0.10%
—
—
—
—
cases:3.39%
controls:0.86%
cases:7.29%
controls:2.92%
23
139
650
6552
19
44
656
6662
6
7
669
6699
—
—
21
56
598
6490
39
167
496
5550
Base excess in Arterial blood by calculation
1925-7 [3003396]
1.3e+00
2.1e+00
—
—
1.0e+50
1.7e+00
8.6e-01
cases:4.16%
controls:1.18%
cases:4.74%
controls:0.60%
—
—
—
—
cases:4.65%
controls:0.00%
cases:3.23%
controls:0.60%
cases:5.42%
controls:2.38%
28
79
645
6612
32
40
643
6666
—
—
31
0
635
6695
20
39
599
6507
29
136
506
5581
Differential panel - Cerebral spinal fluid
29584-0 [3016018]
2.5e+00
—
—
—
1.0e+50
1.0e+50
3.4e+00
cases:1.63%
controls:0.13%
—
—
—
—
—
—
cases:4.95%
controls:0.00%
cases:4.04%
controls:0.00%
cases:3.18%
controls:0.10%
11
9
662
6682
—
—
—
33
0
633
6695
25
0
594
6546
17
6
518
5711
Incontinence urine
U04 [2002001139]
1.4e+00
1.9e+00
—
—
—
2.1e+00
1.8e+00
cases:1.49%
controls:0.39%
cases:1.04%
controls:0.15%
—
—
—
—
—
—
cases:1.29%
controls:0.15%
cases:3.36%
controls:0.58%
10
26
663
6665
7
10
668
6696
—
—
—
8
10
611
6536
18
33
517
5684
Infiltration anesthesia
WX110 [2001310767]
1.3e-01
8.4e-01
1.6e+00
—
2.0e+00
1.0e+00
5.2e-01
cases:15.90%
controls:14.23%
cases:12.30%
controls:5.70%
cases:3.11%
controls:0.67%
—
—
cases:5.56%
controls:0.82%
cases:15.51%
controls:6.32%
cases:26.73%
controls:17.81%
107
952
566
5739
83
382
592
6324
21
45
654
6661
—
37
55
629
6640
96
414
523
6132
143
1018
392
4699
Physiotherapy
R4110 [2001310233]
1.9e-01
1.3e+00
—
1.0e+50
2.9e+00
1.6e+00
4.5e-01
cases:4.90%
controls:4.08%
cases:5.48%
controls:1.51%
—
—
cases:1.93%
controls:0.00%
cases:2.40%
controls:0.13%
cases:6.62%
controls:1.47%
cases:6.54%
controls:4.29%
33
273
640
6418
37
101
638
6605
—
13
0
662
6706
16
9
650
6686
41
96
578
6450
35
245
500
5472
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
1.2e+00
2.4e+00
—
—
1.0e+50
2.2e+00
6.6e-01
cases:2.23%
controls:0.69%
cases:3.11%
controls:0.30%
—
—
—
—
cases:1.95%
controls:0.00%
cases:1.78%
controls:0.20%
cases:2.62%
controls:1.36%
15
46
658
6645
21
20
654
6686
—
—
13
0
653
6695
11
13
608
6533
14
78
521
5639
Oncology Clinic/Center
261QX0200X [38004268]
3.0e-01
8.2e-01
2.0e+00
—
2.9e+00
-5.0e-02
5.4e-02
cases:6.98%
controls:5.28%
cases:3.56%
controls:1.60%
cases:1.19%
controls:0.16%
—
—
cases:1.95%
controls:0.10%
cases:1.45%
controls:1.53%
cases:5.98%
controls:5.68%
47
353
626
6338
24
107
651
6599
8
11
667
6695
—
13
7
653
6688
9
100
610
6446
32
325
503
5392
Osmolality of Urine
2695-5 [3026782]
9.8e-02
1.0e+00
2.4e+00
—
2.3e+00
8.3e-01
5.4e-01
cases:3.42%
controls:3.11%
cases:3.26%
controls:1.22%
cases:1.63%
controls:0.15%
—
—
cases:2.40%
controls:0.24%
cases:2.42%
controls:1.07%
cases:6.73%
controls:4.02%
23
208
650
6483
22
82
653
6624
11
10
664
6696
—
16
16
650
6679
15
70
604
6476
36
230
499
5487
Laboratory Visit
OMOP4822461 [32036]
-5.6e-02
2.1e-01
1.1e+00
3.4e+00
1.2e+00
1.8e-01
1.2e-02
cases:31.05%
controls:32.27%
cases:34.67%
controls:30.08%
cases:22.52%
controls:9.08%
cases:18.22%
controls:0.76%
cases:26.88%
controls:9.68%
cases:35.70%
controls:31.71%
cases:47.29%
controls:47.00%
209
2159
464
4532
234
2017
441
4689
152
609
523
6097
123
51
552
6655
179
648
487
6047
221
2076
398
4470
253
2687
282
3030
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
1.2e+00
2.4e+00
—
—
1.0e+50
2.1e+00
6.8e-01
cases:2.23%
controls:0.67%
cases:3.11%
controls:0.30%
—
—
—
—
cases:2.10%
controls:0.00%
cases:1.78%
controls:0.23%
cases:2.80%
controls:1.43%
15
45
658
6646
21
20
654
6686
—
—
14
0
652
6695
11
15
608
6531
15
82
520
5635
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
1.2e+00
2.3e+00
—
—
1.0e+50
2.1e+00
7.6e-01
cases:2.23%
controls:0.69%
cases:3.11%
controls:0.31%
—
—
—
—
cases:2.10%
controls:0.00%
cases:1.78%
controls:0.21%
cases:2.99%
controls:1.42%
15
46
658
6645
21
21
654
6685
—
—
14
0
652
6695
11
14
608
6532
16
81
519
5636
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.0e-01
9.2e-01
1.6e+00
—
2.2e+00
8.9e-01
4.8e-01
cases:4.90%
controls:3.66%
cases:4.89%
controls:2.01%
cases:1.63%
controls:0.34%
—
—
cases:3.15%
controls:0.34%
cases:4.68%
controls:1.97%
cases:9.72%
controls:6.26%
33
245
640
6446
33
135
642
6571
11
23
664
6683
—
21
23
645
6672
29
129
590
6417
52
358
483
5359
Neuropsychological investigation
XA800 [2001300412]
9.2e-01
3.2e+00
—
—
—
—
2.4e+00
cases:0.89%
controls:0.36%
cases:2.07%
controls:0.09%
—
—
—
—
—
—
—
—
cases:4.30%
controls:0.40%
6
24
667
6667
14
6
661
6700
—
—
—
—
23
23
512
5694
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.6e-01
1.2e+00
1.7e+00
—
2.1e+00
4.3e-01
6.1e-01
cases:8.47%
controls:5.50%
cases:8.30%
controls:2.70%
cases:2.07%
controls:0.39%
—
—
cases:3.15%
controls:0.40%
cases:4.52%
controls:2.99%
cases:15.89%
controls:9.31%
57
368
616
6323
56
181
619
6525
14
26
661
6680
—
21
27
645
6668
28
196
591
6350
85
532
450
5185
clobazam; oral
N05BA09 [21604574]
2.9e+00
—
—
—
—
—
2.7e+00
cases:1.78%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.31%
controls:0.09%
12
7
661
6684
—
—
—
—
—
7
5
528
5712
Gas panel - Venous blood
24339-4 [3000991]
1.5e-01
1.4e+00
2.3e+00
—
2.8e+00
1.2e+00
2.8e-01
cases:1.04%
controls:0.90%
cases:1.78%
controls:0.43%
cases:0.74%
controls:0.07%
—
—
cases:1.50%
controls:0.09%
cases:1.94%
controls:0.58%
cases:2.43%
controls:1.85%
7
60
666
6631
12
29
663
6677
5
5
670
6701
—
10
6
656
6689
12
38
607
6508
13
106
522
5611
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
4.2e-01
1.1e+00
1.7e+00
—
1.8e+00
9.5e-01
9.0e-01
cases:2.38%
controls:1.57%
cases:2.07%
controls:0.72%
cases:1.19%
controls:0.22%
—
—
cases:1.50%
controls:0.25%
cases:2.42%
controls:0.95%
cases:5.79%
controls:2.43%
16
105
657
6586
14
48
661
6658
8
15
667
6691
—
10
17
656
6678
15
62
604
6484
31
139
504
5578
Limited function/disability (N)
N28 [2002000733]
2.4e+00
3.0e+00
—
—
—
—
—
cases:1.19%
controls:0.10%
cases:1.48%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
8
7
665
6684
10
5
665
6701
—
—
—
—
—
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
7.3e-01
1.8e+00
—
—
—
2.3e+00
1.3e+00
cases:2.23%
controls:1.09%
cases:2.07%
controls:0.34%
—
—
—
—
—
—
cases:2.75%
controls:0.29%
cases:3.74%
controls:1.03%
15
73
658
6618
14
23
661
6683
—
—
—
17
19
602
6527
20
59
515
5658
Sequelae of intracranial injury
T90.5 [45537098]
—
—
—
—
—
2.7e+00
2.7e+00
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.08%
cases:1.50%
controls:0.10%
—
—
—
—
—
7
5
612
6541
8
6
527
5711
pH of Urine
2756-5 [3015736]
4.6e-01
9.9e-01
1.7e+00
—
2.0e+00
6.7e-01
4.0e-01
cases:9.81%
controls:6.41%
cases:8.15%
controls:3.19%
cases:2.52%
controls:0.45%
—
—
cases:3.90%
controls:0.57%
cases:6.79%
controls:3.59%
cases:15.51%
controls:10.93%
66
429
607
6262
55
214
620
6492
17
30
658
6676
—
26
38
640
6657
42
235
577
6311
83
625
452
5092
Malaise and fatigue
R53 [45553741]
6.3e-01
1.7e+00
2.7e+00
—
—
8.4e-01
9.4e-01
cases:3.57%
controls:1.93%
cases:4.59%
controls:0.86%
cases:1.78%
controls:0.12%
—
—
—
—
cases:2.26%
controls:0.99%
cases:10.09%
controls:4.22%
24
129
649
6562
31
58
644
6648
12
8
663
6698
—
—
14
65
605
6481
54
241
481
5476
Other and unspecified convulsions
R56.8 [45602033]
1.5e+00
1.6e+00
—
—
—
2.5e+00
1.4e+00
cases:1.78%
controls:0.42%
cases:0.74%
controls:0.15%
—
—
—
—
—
—
cases:1.78%
controls:0.15%
cases:2.24%
controls:0.56%
12
28
661
6663
5
10
670
6696
—
—
—
11
10
608
6536
12
32
523
5685
pH of Serum or Plasma
2753-2 [3018418]
3.5e-01
1.1e+00
2.0e+00
1.0e+50
1.6e+00
4.5e-01
5.8e-01
cases:6.24%
controls:4.50%
cases:6.81%
controls:2.36%
cases:2.52%
controls:0.36%
cases:1.04%
controls:0.00%
cases:1.65%
controls:0.33%
cases:3.72%
controls:2.40%
cases:11.96%
controls:7.08%
42
301
631
6390
46
158
629
6548
17
24
658
6682
7
0
668
6706
11
22
655
6673
23
157
596
6389
64
405
471
5312
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
4.1e-01
7.0e-01
2.0e+00
1.0e+50
2.6e+00
4.2e-01
6.5e-01
cases:3.71%
controls:2.50%
cases:2.37%
controls:1.19%
cases:1.78%
controls:0.24%
cases:1.63%
controls:0.00%
cases:2.10%
controls:0.16%
cases:1.78%
controls:1.18%
cases:7.29%
controls:3.94%
25
167
648
6524
16
80
659
6626
12
16
663
6690
11
0
664
6706
14
11
652
6684
11
77
608
6469
39
225
496
5492
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
2.8e-01
7.6e-01
1.7e+00
—
2.3e+00
3.6e-01
4.6e-01
cases:7.73%
controls:5.96%
cases:8.30%
controls:4.06%
cases:3.41%
controls:0.63%
—
—
cases:5.26%
controls:0.55%
cases:5.49%
controls:3.88%
cases:14.95%
controls:10.02%
52
399
621
6292
56
272
619
6434
23
42
652
6664
—
35
37
631
6658
34
254
585
6292
80
573
455
5144
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
3.7e-01
7.3e-01
1.0e+00
—
1.4e+00
1.1e+00
5.9e-01
cases:36.85%
controls:28.64%
cases:28.74%
controls:16.21%
cases:8.30%
controls:3.09%
—
—
cases:11.41%
controls:3.17%
cases:36.51%
controls:16.64%
cases:53.08%
controls:38.66%
248
1916
425
4775
194
1087
481
5619
56
207
619
6499
—
76
212
590
6483
226
1089
393
5457
284
2210
251
3507
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
6.1e-01
—
—
—
—
3.0e+00
2.2e+00
cases:0.74%
controls:0.40%
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.08%
cases:2.24%
controls:0.26%
5
27
668
6664
—
—
—
—
9
5
610
6541
12
15
523
5702
macrogol; oral
A06AD15 [21600575]
6.9e-01
1.7e+00
—
—
—
1.9e+00
1.5e+00
cases:1.49%
controls:0.75%
cases:2.22%
controls:0.42%
—
—
—
—
—
—
cases:2.91%
controls:0.44%
cases:7.48%
controls:1.75%
10
50
663
6641
15
28
660
6678
—
—
—
18
29
601
6517
40
100
495
5617
lactulose; oral
A06AD11 [21600571]
6.1e-01
1.1e+00
1.1e+00
—
1.6e+00
1.5e+00
9.3e-01
cases:3.71%
controls:2.06%
cases:3.56%
controls:1.18%
cases:1.19%
controls:0.40%
—
—
cases:1.35%
controls:0.28%
cases:4.85%
controls:1.16%
cases:7.10%
controls:2.94%
25
138
648
6553
24
79
651
6627
8
27
667
6679
—
9
19
657
6676
30
76
589
6470
38
168
497
5549
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
8.5e-01
1.6e+00
—
1.0e+50
—
3.1e+00
2.0e+00
cases:1.63%
controls:0.70%
cases:1.19%
controls:0.25%
—
—
cases:0.89%
controls:0.00%
—
—
cases:3.23%
controls:0.15%
cases:5.42%
controls:0.77%
11
47
662
6644
8
17
667
6689
—
6
0
669
6706
—
20
10
599
6536
29
44
506
5673
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
4.2e-01
1.1e+00
1.6e+00
—
1.3e+00
1.4e+00
1.0e+00
cases:6.69%
controls:4.48%
cases:4.44%
controls:1.52%
cases:1.48%
controls:0.31%
—
—
cases:1.35%
controls:0.37%
cases:6.14%
controls:1.57%
cases:11.40%
controls:4.51%
45
300
628
6391
30
102
645
6604
10
21
665
6685
—
9
25
657
6670
38
103
581
6443
61
258
474
5459
ABO and Rh group [Type] in Blood
882-1 [3003694]
5.3e-01
1.0e+00
1.9e+00
1.0e+50
2.7e+00
1.3e+00
-2.8e-01
cases:5.05%
controls:3.05%
cases:3.11%
controls:1.13%
cases:0.89%
controls:0.13%
cases:2.07%
controls:0.00%
cases:1.35%
controls:0.09%
cases:3.07%
controls:0.84%
cases:2.99%
controls:3.90%
34
204
639
6487
21
76
654
6630
6
9
669
6697
14
0
661
6706
9
6
657
6689
19
55
600
6491
16
223
519
5494
trimethoprim; oral, parenteral
J01EA01 [21602931]
7.4e-01
8.5e-01
1.7e+00
—
1.2e+00
9.9e-01
8.2e-01
cases:10.55%
controls:5.31%
cases:4.74%
controls:2.07%
cases:1.63%
controls:0.31%
—
—
cases:1.05%
controls:0.31%
cases:5.65%
controls:2.18%
cases:13.46%
controls:6.42%
71
355
602
6336
32
139
643
6567
11
21
664
6685
—
7
21
659
6674
35
143
584
6403
72
367
463
5350
General Surgery
2 [38004447]
3.5e-01
7.4e-01
1.4e+00
—
1.4e+00
7.4e-01
4.2e-01
cases:26.45%
controls:20.25%
cases:12.30%
controls:6.26%
cases:3.26%
controls:0.85%
—
—
cases:3.15%
controls:0.79%
cases:11.63%
controls:5.88%
cases:24.11%
controls:17.33%
178
1355
495
5336
83
420
592
6286
22
57
653
6649
—
21
53
645
6642
72
385
547
6161
129
991
406
4726
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
8.7e-01
2.1e+00
—
—
—
1.8e+00
1.1e+00
cases:2.23%
controls:0.94%
cases:2.22%
controls:0.28%
—
—
—
—
—
—
cases:2.26%
controls:0.37%
cases:5.23%
controls:1.84%
15
63
658
6628
15
19
660
6687
—
—
—
14
24
605
6522
28
105
507
5612
Diplopia
H53.2 [45576792]
1.3e+00
—
—
—
—
2.7e+00
2.3e+00
cases:0.89%
controls:0.25%
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.08%
cases:1.87%
controls:0.19%
6
17
667
6674
—
—
—
—
7
5
612
6541
10
11
525
5706
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
7.1e-02
4.5e-01
1.2e+00
2.3e+00
1.5e+00
1.6e-01
3.2e-01
cases:9.96%
controls:9.34%
cases:8.89%
controls:5.85%
cases:4.00%
controls:1.24%
cases:1.04%
controls:0.10%
cases:5.71%
controls:1.36%
cases:6.95%
controls:5.96%
cases:17.76%
controls:13.57%
67
625
606
6066
60
392
615
6314
27
83
648
6623
7
7
668
6699
38
91
628
6604
43
390
576
6156
95
776
440
4941
One hour or less
ZXE00 [2001311394]
3.0e-01
8.4e-01
1.6e+00
1.0e+50
2.3e+00
1.1e+00
6.8e-01
cases:7.73%
controls:5.81%
cases:3.70%
controls:1.63%
cases:0.89%
controls:0.18%
cases:2.52%
controls:0.00%
cases:1.65%
controls:0.16%
cases:4.52%
controls:1.53%
cases:8.79%
controls:4.64%
52
389
621
6302
25
109
650
6597
6
12
669
6694
17
0
658
6706
11
11
655
6684
28
100
591
6446
47
265
488
5452
Appearance of Cerebral spinal fluid
10333-3 [3023410]
2.1e+00
—
—
—
1.0e+50
1.0e+50
2.8e+00
cases:1.49%
controls:0.18%
—
—
—
—
—
—
cases:3.00%
controls:0.00%
cases:2.10%
controls:0.00%
cases:2.06%
controls:0.12%
10
12
663
6679
—
—
—
20
0
646
6695
13
0
606
6546
11
7
524
5710
Geriatric Medicine
38 [38004478]
4.5e-01
2.2e+00
—
—
—
1.8e+00
9.7e-01
cases:0.89%
controls:0.57%
cases:2.07%
controls:0.24%
—
—
—
—
—
—
cases:1.94%
controls:0.32%
cases:2.99%
controls:1.15%
6
38
667
6653
14
16
661
6690
—
—
—
12
21
607
6525
16
66
519
5651
12 lead EKG panel
34534-8 [3044889]
4.6e-01
6.1e-01
1.4e+00
—
1.9e+00
6.4e-01
3.3e-01
cases:20.36%
controls:13.94%
cases:12.74%
controls:7.32%
cases:2.67%
controls:0.70%
—
—
cases:5.71%
controls:0.91%
cases:12.60%
controls:7.04%
cases:23.93%
controls:18.45%
137
933
536
5758
86
491
589
6215
18
47
657
6659
—
38
61
628
6634
78
461
541
6085
128
1055
407
4662
Benign tumor of the meninges at the base of the brain
D32.02 [2000501309]
2.5e+00
2.5e+00
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.04%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
6
5
667
6686
7
6
668
6700
—
—
—
—
—
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
5.1e-01
1.6e+00
2.3e+00
—
—
6.6e-01
9.9e-01
cases:1.93%
controls:1.17%
cases:2.37%
controls:0.48%
cases:0.89%
controls:0.09%
—
—
—
—
cases:0.97%
controls:0.50%
cases:4.86%
controls:1.87%
13
78
660
6613
16
32
659
6674
6
6
669
6700
—
—
6
33
613
6513
26
107
509
5610
baclofen; oral, parenteral
M03BX01 [21604115]
—
—
—
—
—
2.4e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.08%
cases:2.24%
controls:0.19%
—
—
—
—
—
5
5
614
6541
12
11
523
5706
Other and unspecified abnormalities of gait and mobility
R26.8 [45597174]
2.7e+00
—
—
—
—
—
2.1e+00
cases:1.78%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.23%
12
8
661
6683
—
—
—
—
—
10
13
525
5704
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
7.3e-01
1.1e+00
1.9e+00
—
—
1.0e+00
4.9e-01
cases:5.94%
controls:2.96%
cases:3.41%
controls:1.15%
cases:1.04%
controls:0.15%
—
—
—
—
cases:3.55%
controls:1.31%
cases:5.05%
controls:3.15%
40
198
633
6493
23
77
652
6629
7
10
668
6696
—
—
22
86
597
6460
27
180
508
5537
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-8.4e-04
3.3e-01
1.1e+00
2.3e+00
1.1e+00
1.0e-01
3.8e-02
cases:25.85%
controls:25.87%
cases:25.78%
controls:19.95%
cases:8.89%
controls:3.13%
cases:2.22%
controls:0.24%
cases:9.61%
controls:3.41%
cases:21.65%
controls:19.97%
cases:39.25%
controls:38.34%
174
1731
499
4960
174
1338
501
5368
60
210
615
6496
15
16
660
6690
64
228
602
6467
134
1307
485
5239
210
2192
325
3525
Cells panel - Urine sediment
58434-2 [40761535]
5.9e-01
7.4e-01
2.3e+00
—
2.0e+00
1.2e+00
1.2e+00
cases:2.53%
controls:1.42%
cases:1.33%
controls:0.64%
cases:0.89%
controls:0.09%
—
—
cases:0.75%
controls:0.10%
cases:2.42%
controls:0.72%
cases:5.05%
controls:1.52%
17
95
656
6596
9
43
666
6663
6
6
669
6700
—
5
7
661
6688
15
47
604
6499
27
87
508
5630
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
1.9e+00
—
1.0e+50
1.0e+50
—
—
2.9e+00
cases:1.63%
controls:0.25%
—
—
cases:0.74%
controls:0.00%
cases:2.07%
controls:0.00%
—
—
—
—
cases:1.87%
controls:0.10%
11
17
662
6674
—
5
0
670
6706
14
0
661
6706
—
—
10
6
525
5711
Assessment of need for aid
SPAT1229 [2001700330]
9.6e-01
1.6e+00
—
—
—
2.0e+00
1.1e+00
cases:1.78%
controls:0.69%
cases:1.19%
controls:0.24%
—
—
—
—
—
—
cases:1.62%
controls:0.21%
cases:3.18%
controls:1.07%
12
46
661
6645
8
16
667
6690
—
—
—
10
14
609
6532
17
61
518
5656
desmopressin; nasal, oral, parenteral, sublingual
H01BA02 [21602700]
1.7e+00
2.3e+00
—
—
—
2.4e+00
2.4e+00
cases:0.89%
controls:0.16%
cases:0.74%
controls:0.07%
—
—
—
—
—
—
cases:0.81%
controls:0.08%
cases:0.93%
controls:0.09%
6
11
667
6680
5
5
670
6701
—
—
—
5
5
614
6541
5
5
530
5712
citalopram; oral, parenteral
N06AB04 [21604712]
7.6e-01
9.1e-01
1.3e+00
—
1.2e+00
9.1e-01
9.3e-01
cases:7.43%
controls:3.60%
cases:5.19%
controls:2.15%
cases:1.48%
controls:0.40%
—
—
cases:1.95%
controls:0.58%
cases:5.65%
controls:2.35%
cases:8.41%
controls:3.50%
50
241
623
6450
35
144
640
6562
10
27
665
6679
—
13
39
653
6656
35
154
584
6392
45
200
490
5517
Removal of sutures
SPAT1153 [2001700254]
4.6e-01
7.8e-01
2.1e+00
—
3.2e+00
1.5e+00
5.4e-01
cases:6.84%
controls:4.44%
cases:3.26%
controls:1.52%
cases:0.74%
controls:0.09%
—
—
cases:2.10%
controls:0.09%
cases:5.65%
controls:1.28%
cases:8.22%
controls:4.95%
46
297
627
6394
22
102
653
6604
5
6
670
6700
—
14
6
652
6689
35
84
584
6462
44
283
491
5434
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
9.8e-01
1.9e+00
—
—
—
1.4e+00
1.2e+00
cases:1.19%
controls:0.45%
cases:1.33%
controls:0.19%
—
—
—
—
—
—
cases:1.78%
controls:0.43%
cases:3.55%
controls:1.08%
8
30
665
6661
9
13
666
6693
—
—
—
11
28
608
6518
19
62
516
5655
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
1.6e-01
6.3e-01
2.2e+00
1.0e+50
1.7e+00
7.7e-01
7.0e-01
cases:3.42%
controls:2.91%
cases:2.67%
controls:1.43%
cases:1.33%
controls:0.15%
cases:1.19%
controls:0.00%
cases:1.20%
controls:0.22%
cases:3.39%
controls:1.60%
cases:8.41%
controls:4.37%
23
195
650
6496
18
96
657
6610
9
10
666
6696
8
0
667
6706
8
15
658
6680
21
105
598
6441
45
250
490
5467
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
1.8e+00
2.8e+00
—
—
1.0e+50
—
9.7e-01
cases:1.93%
controls:0.33%
cases:2.07%
controls:0.13%
—
—
—
—
cases:0.90%
controls:0.00%
—
—
cases:1.68%
controls:0.65%
13
22
660
6669
14
9
661
6697
—
—
6
0
660
6695
—
9
37
526
5680
Case Management Agency
251B00000X [38004193]
1.9e-01
1.2e-01
7.2e-01
3.2e+00
6.1e-01
2.5e-01
1.1e-01
cases:57.36%
controls:52.62%
cases:49.33%
controls:46.24%
cases:32.15%
controls:18.74%
cases:24.74%
controls:1.36%
cases:30.48%
controls:19.28%
cases:55.57%
controls:49.37%
cases:72.52%
controls:70.30%
386
3521
287
3170
333
3101
342
3605
217
1257
458
5449
167
91
508
6615
203
1291
463
5404
344
3232
275
3314
388
4019
147
1698
Fitting and adjustment of other specified devices
Z46.8 [45581035]
—
—
—
—
—
2.4e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.09%
cases:1.87%
controls:0.23%
—
—
—
—
—
6
6
613
6540
10
13
525
5704
Epilepsy and comparable convulsive disorders
111 [2001600111]
2.0e+00
2.3e+00
—
—
—
—
2.5e+00
cases:1.93%
controls:0.27%
cases:0.74%
controls:0.07%
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.23%
13
18
660
6673
5
5
670
6701
—
—
—
—
14
13
521
5704
Paralysis/weakness
N18 [2002000729]
1.6e+00
—
—
—
—
2.6e+00
1.8e+00
cases:0.89%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.11%
cases:1.68%
controls:0.28%
6
12
667
6679
—
—
—
—
9
7
610
6539
9
16
526
5701
mirtazapine; oral
N06AX11 [21604740]
7.7e-01
9.1e-01
1.1e+00
—
9.1e-01
9.4e-01
6.9e-01
cases:11.44%
controls:5.62%
cases:7.56%
controls:3.19%
cases:2.81%
controls:0.95%
—
—
cases:1.95%
controls:0.79%
cases:9.05%
controls:3.74%
cases:14.21%
controls:7.66%
77
376
596
6315
51
214
624
6492
19
64
656
6642
—
13
53
653
6642
56
245
563
6301
76
438
459
5279
Subarachnoid haemorrhage, unspecified
I60.9 [45591472]
2.2e+00
—
1.0e+50
1.0e+50
1.0e+50
—
2.2e+00
cases:1.19%
controls:0.13%
—
—
cases:2.52%
controls:0.00%
cases:1.93%
controls:0.00%
cases:1.35%
controls:0.00%
—
—
cases:1.12%
controls:0.12%
8
9
665
6682
—
17
0
658
6706
13
0
662
6706
9
0
657
6695
—
6
7
529
5710
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.3e+00
—
—
—
—
2.7e+00
1.7e+00
cases:1.04%
controls:0.28%
—
—
—
—
—
—
—
—
cases:2.10%
controls:0.14%
cases:2.43%
controls:0.47%
7
19
666
6672
—
—
—
—
13
9
606
6537
13
27
522
5690
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
1.8e+00
2.6e+00
—
—
1.0e+50
2.0e+00
9.7e-01
cases:2.08%
controls:0.36%
cases:2.22%
controls:0.16%
—
—
—
—
cases:0.90%
controls:0.00%
cases:0.81%
controls:0.11%
cases:1.87%
controls:0.72%
14
24
659
6667
15
11
660
6695
—
—
6
0
660
6695
5
7
614
6539
10
41
525
5676
General anaesthesia
WX402 [2001310806]
4.6e-01
1.5e+00
—
1.0e+50
—
1.9e+00
9.9e-01
cases:2.82%
controls:1.81%
cases:3.70%
controls:0.84%
—
—
cases:4.00%
controls:0.00%
—
—
cases:4.85%
controls:0.78%
cases:6.17%
controls:2.38%
19
121
654
6570
25
56
650
6650
—
27
0
648
6706
—
30
51
589
6495
33
136
502
5581
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
F00.20*G30.8 [2000501580]
—
—
—
—
—
2.4e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.09%
cases:1.87%
controls:0.26%
—
—
—
—
—
6
6
613
6540
10
15
525
5702
Scheduled procedure
ZXD10 [2001311387]
1.3e-01
6.5e-01
—
1.0e+50
2.6e+00
1.7e+00
4.1e-01
cases:7.13%
controls:6.32%
cases:3.11%
controls:1.66%
—
—
cases:0.89%
controls:0.00%
cases:2.25%
controls:0.16%
cases:7.43%
controls:1.50%
cases:6.54%
controls:4.44%
48
423
625
6268
21
111
654
6595
—
6
0
669
6706
15
11
651
6684
46
98
573
6448
35
254
500
5463
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
7.9e-01
2.0e+00
—
1.0e+50
—
2.1e+00
7.1e-01
cases:1.34%
controls:0.61%
cases:2.37%
controls:0.31%
—
—
cases:1.04%
controls:0.00%
—
—
cases:2.26%
controls:0.27%
cases:2.24%
controls:1.12%
9
41
664
6650
16
21
659
6685
—
7
0
668
6706
—
14
18
605
6528
12
64
523
5653
Ophthalmology
18 [38004463]
2.9e-01
4.6e-01
1.2e+00
—
1.0e+00
1.0e+00
4.4e-01
cases:20.36%
controls:16.11%
cases:11.41%
controls:7.55%
cases:4.15%
controls:1.31%
—
—
cases:4.35%
controls:1.60%
cases:17.77%
controls:7.10%
cases:27.85%
controls:19.87%
137
1078
536
5613
77
506
598
6200
28
88
647
6618
—
29
107
637
6588
110
465
509
6081
149
1136
386
4581
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
1.1e+00
1.8e+00
—
1.0e+50
1.0e+50
2.4e+00
8.9e-01
cases:1.49%
controls:0.48%
cases:1.63%
controls:0.28%
—
—
cases:1.48%
controls:0.00%
cases:2.85%
controls:0.00%
cases:1.94%
controls:0.18%
cases:2.80%
controls:1.17%
10
32
663
6659
11
19
664
6687
—
10
0
665
6706
19
0
647
6695
12
12
607
6534
15
67
520
5650
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
2.1e-01
9.5e-01
2.3e+00
—
1.4e+00
6.3e-01
8.4e-01
cases:4.01%
controls:3.29%
cases:2.81%
controls:1.10%
cases:0.89%
controls:0.09%
—
—
cases:0.75%
controls:0.19%
cases:1.62%
controls:0.87%
cases:6.17%
controls:2.76%
27
220
646
6471
19
74
656
6632
6
6
669
6700
—
5
13
661
6682
10
57
609
6489
33
158
502
5559
Occupational therapy
R4120 [2001310234]
—
2.2e+00
—
—
—
1.9e+00
9.9e-01
—
—
cases:1.04%
controls:0.12%
—
—
—
—
—
—
cases:1.13%
controls:0.17%
cases:1.87%
controls:0.70%
—
7
8
668
6698
—
—
—
7
11
612
6535
10
40
525
5677
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
1.9e+00
2.1e+00
—
—
—
—
—
cases:1.04%
controls:0.16%
cases:0.89%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
7
11
666
6680
6
7
669
6699
—
—
—
—
—
Tension-type headache
G44.2 [45581495]
9.4e-01
1.7e+00
—
—
—
1.4e+00
1.3e+00
cases:2.97%
controls:1.18%
cases:1.63%
controls:0.30%
—
—
—
—
—
—
cases:1.13%
controls:0.29%
cases:4.49%
controls:1.21%
20
79
653
6612
11
20
664
6686
—
—
—
7
19
612
6527
24
69
511
5648
acetylsalicylic acid; oral
B01AC06 [21600991]
3.7e-01
8.0e-01
1.1e+00
—
1.4e+00
8.5e-01
9.1e-01
cases:3.86%
controls:2.71%
cases:3.70%
controls:1.70%
cases:1.63%
controls:0.55%
—
—
cases:2.10%
controls:0.54%
cases:4.36%
controls:1.91%
cases:8.97%
controls:3.81%
26
181
647
6510
25
114
650
6592
11
37
664
6669
—
14
36
652
6659
27
125
592
6421
48
218
487
5499
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
6.4e-01
1.3e+00
—
—
2.6e+00
1.9e-01
4.9e-01
cases:2.97%
controls:1.58%
cases:3.85%
controls:1.06%
—
—
—
—
cases:2.40%
controls:0.18%
cases:1.29%
controls:1.07%
cases:4.30%
controls:2.68%
20
106
653
6585
26
71
649
6635
—
—
16
12
650
6683
8
70
611
6476
23
153
512
5564
clozapine; oral, parenteral
N05AH02 [21604542]
1.9e+00
2.1e+00
1.7e+00
—
1.7e+00
1.4e+00
1.5e+00
cases:1.34%
controls:0.21%
cases:1.63%
controls:0.21%
cases:0.89%
controls:0.16%
—
—
cases:0.90%
controls:0.16%
cases:0.81%
controls:0.20%
cases:0.93%
controls:0.21%
9
14
664
6677
11
14
664
6692
6
11
669
6695
—
6
11
660
6684
5
13
614
6533
5
12
530
5705
Hypothyroidism, unspecified
E03.9 [45537945]
3.7e-01
1.2e+00
—
—
2.0e+00
8.1e-01
7.3e-01
cases:2.67%
controls:1.87%
cases:2.07%
controls:0.66%
—
—
—
—
cases:0.90%
controls:0.12%
cases:1.94%
controls:0.87%
cases:5.23%
controls:2.59%
18
125
655
6566
14
44
661
6662
—
—
6
8
660
6687
12
57
607
6489
28
148
507
5569
quetiapine; oral
N05AH04 [21604544]
9.0e-01
1.0e+00
9.2e-01
—
5.4e-01
1.1e+00
8.7e-01
cases:6.09%
controls:2.57%
cases:4.74%
controls:1.74%
cases:1.63%
controls:0.66%
—
—
cases:1.05%
controls:0.61%
cases:5.01%
controls:1.74%
cases:7.85%
controls:3.45%
41
172
632
6519
32
117
643
6589
11
44
664
6662
—
7
41
659
6654
31
114
588
6432
42
197
493
5520
Asthma, unspecified
J45.9 [45562456]
2.5e-01
8.8e-01
1.9e+00
—
1.0e+00
1.1e+00
4.3e-01
cases:3.86%
controls:3.05%
cases:2.96%
controls:1.25%
cases:1.33%
controls:0.19%
—
—
cases:0.90%
controls:0.33%
cases:4.04%
controls:1.44%
cases:6.54%
controls:4.37%
26
204
647
6487
20
84
655
6622
9
13
666
6693
—
6
22
660
6673
25
94
594
6452
35
250
500
5467
Pediatric Surgery
OMOP4822020 [45756819]
1.6e+00
1.3e+00
—
—
—
2.2e+00
1.3e+00
cases:1.19%
controls:0.24%
cases:0.74%
controls:0.21%
—
—
—
—
—
—
cases:0.97%
controls:0.11%
cases:2.06%
controls:0.59%
8
16
665
6675
5
14
670
6692
—
—
—
6
7
613
6539
11
34
524
5683
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2.7e-01
6.1e-01
1.6e+00
—
1.6e+00
9.8e-02
6.0e-01
cases:5.94%
controls:4.59%
cases:4.59%
controls:2.55%
cases:1.63%
controls:0.33%
—
—
cases:1.95%
controls:0.42%
cases:2.91%
controls:2.64%
cases:12.52%
controls:7.28%
40
307
633
6384
31
171
644
6535
11
22
664
6684
—
13
28
653
6667
18
173
601
6373
67
416
468
5301
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
4.6e-01
1.0e+00
—
—
2.7e+00
7.8e-01
2.7e-01
cases:2.67%
controls:1.70%
cases:2.96%
controls:1.07%
—
—
—
—
cases:2.25%
controls:0.15%
cases:2.26%
controls:1.05%
cases:5.05%
controls:3.88%
18
114
655
6577
20
72
655
6634
—
—
15
10
651
6685
14
69
605
6477
27
222
508
5495
Intubation
WX704 [2001310820]
8.7e-01
1.1e+00
—
1.0e+50
—
2.3e+00
1.5e+00
cases:1.49%
controls:0.63%
cases:0.89%
controls:0.30%
—
—
cases:2.07%
controls:0.00%
—
—
cases:1.94%
controls:0.20%
cases:3.18%
controls:0.75%
10
42
663
6649
6
20
669
6686
—
14
0
661
6706
—
12
13
607
6533
17
43
518
5674
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
1.2e-01
3.3e-01
1.7e+00
2.3e+00
2.0e+00
1.9e-01
-9.2e-02
cases:12.18%
controls:10.93%
cases:7.56%
controls:5.53%
cases:2.67%
controls:0.48%
cases:0.74%
controls:0.07%
cases:5.41%
controls:0.78%
cases:5.65%
controls:4.71%
cases:14.02%
controls:15.17%
82
731
591
5960
51
371
624
6335
18
32
657
6674
5
5
670
6701
36
52
630
6643
35
308
584
6238
75
867
460
4850
Lactate [Moles/volume] in Blood
32693-4 [3047181]
1.6e+00
1.4e+00
—
1.0e+50
1.0e+50
2.1e+00
1.1e+00
cases:1.49%
controls:0.30%
cases:0.74%
controls:0.18%
—
—
cases:1.48%
controls:0.00%
cases:2.10%
controls:0.00%
cases:0.97%
controls:0.12%
cases:1.50%
controls:0.52%
10
20
663
6671
5
12
670
6694
—
10
0
665
6706
14
0
652
6695
6
8
613
6538
8
30
527
5687
Voluntary or Charitable Agency
251V00000X [38004202]
1.7e+00
—
—
—
—
—
1.9e+00
cases:1.34%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:3.18%
controls:0.47%
9
16
664
6675
—
—
—
—
—
17
27
518
5690
Depressive episode, unspecified
F32.9 [45571760]
8.0e-01
1.1e+00
—
—
2.5e+00
9.3e-01
1.2e+00
cases:2.82%
controls:1.29%
cases:1.19%
controls:0.42%
—
—
—
—
cases:0.90%
controls:0.07%
cases:1.45%
controls:0.58%
cases:4.30%
controls:1.38%
19
86
654
6605
8
28
667
6678
—
—
6
5
660
6690
9
38
610
6508
23
79
512
5638
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
2.9e-01
1.3e+00
—
—
2.3e+00
3.7e-01
6.6e-01
cases:1.34%
controls:1.00%
cases:2.81%
controls:0.76%
—
—
—
—
cases:1.50%
controls:0.15%
cases:0.97%
controls:0.67%
cases:3.55%
controls:1.87%
9
67
664
6624
19
51
656
6655
—
—
10
10
656
6685
6
44
613
6502
19
107
516
5610
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
1.2e+00
2.1e+00
—
—
—
—
1.5e+00
cases:0.89%
controls:0.27%
cases:0.89%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.38%
6
18
667
6673
6
7
669
6699
—
—
—
—
9
22
526
5695
escitalopram; oral
N06AB10 [21604718]
7.7e-01
7.6e-01
8.6e-01
—
6.2e-01
9.9e-01
1.1e+00
cases:5.79%
controls:2.78%
cases:3.70%
controls:1.76%
cases:1.19%
controls:0.51%
—
—
cases:1.05%
controls:0.57%
cases:4.85%
controls:1.86%
cases:9.91%
controls:3.48%
39
186
634
6505
25
118
650
6588
8
34
667
6672
—
7
38
659
6657
30
122
589
6424
53
199
482
5518
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
3.8e-01
9.6e-01
1.3e+00
—
2.7e+00
6.7e-01
1.1e-01
cases:2.53%
controls:1.75%
cases:2.52%
controls:0.98%
cases:0.74%
controls:0.19%
—
—
cases:2.10%
controls:0.15%
cases:1.78%
controls:0.92%
cases:3.93%
controls:3.52%
17
117
656
6574
17
66
658
6640
5
13
670
6693
—
14
10
652
6685
11
60
608
6486
21
201
514
5516
Spinal stenosis
M48.0 [45557888]
8.0e-01
1.5e+00
—
1.0e+50
1.6e+00
1.3e+00
6.0e-01
cases:3.86%
controls:1.78%
cases:2.81%
controls:0.66%
—
—
cases:0.89%
controls:0.00%
cases:0.75%
controls:0.15%
cases:3.07%
controls:0.82%
cases:4.11%
controls:2.29%
26
119
647
6572
19
44
656
6662
—
6
0
669
6706
5
10
661
6685
19
54
600
6492
22
131
513
5586
Physical Medicine And Rehabilitation
25 [38004468]
6.7e-01
1.2e+00
9.2e-01
—
1.3e+00
1.1e+00
6.3e-01
cases:11.59%
controls:6.28%
cases:6.37%
controls:2.03%
cases:1.19%
controls:0.48%
—
—
cases:1.35%
controls:0.36%
cases:6.62%
controls:2.32%
cases:11.96%
controls:6.73%
78
420
595
6271
43
136
632
6570
8
32
667
6674
—
9
24
657
6671
41
152
578
6394
64
385
471
5332
venlafaxine; oral
N06AX16 [21604745]
7.5e-01
1.2e+00
1.0e+00
—
1.1e+00
1.1e+00
1.2e+00
cases:3.71%
controls:1.79%
cases:3.41%
controls:1.04%
cases:1.04%
controls:0.37%
—
—
cases:0.75%
controls:0.25%
cases:3.55%
controls:1.22%
cases:5.42%
controls:1.64%
25
120
648
6571
23
70
652
6636
7
25
668
6681
—
5
17
661
6678
22
80
597
6466
29
94
506
5623
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
3.1e-01
1.7e+00
—
—
—
1.9e+00
4.5e-01
cases:1.04%
controls:0.76%
cases:1.93%
controls:0.37%
—
—
—
—
—
—
cases:2.42%
controls:0.38%
cases:2.80%
controls:1.80%
7
51
666
6640
13
25
662
6681
—
—
—
15
25
604
6521
15
103
520
5614
sertraline; oral
N06AB06 [21604714]
1.2e+00
1.1e+00
—
—
—
8.8e-01
1.2e+00
cases:3.57%
controls:1.11%
cases:2.22%
controls:0.73%
—
—
—
—
—
—
cases:1.45%
controls:0.61%
cases:3.55%
controls:1.10%
24
74
649
6617
15
49
660
6657
—
—
—
9
40
610
6506
19
63
516
5654
Memory disturbance
P20 [2002000816]
7.1e-01
1.4e+00
—
—
—
1.1e+00
1.0e+00
cases:2.97%
controls:1.48%
cases:2.96%
controls:0.78%
—
—
—
—
—
—
cases:2.10%
controls:0.69%
cases:7.29%
controls:2.80%
20
99
653
6592
20
52
655
6654
—
—
—
13
45
606
6501
39
160
496
5557
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
1.7e+00
1.8e+00
—
—
—
—
1.3e+00
cases:1.49%
controls:0.27%
cases:1.04%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.24%
10
18
663
6673
7
12
668
6694
—
—
—
—
5
14
530
5703
Nursing episode
950 [44777714]
7.4e-01
1.3e+00
—
—
9.3e-01
1.2e+00
9.7e-01
cases:2.53%
controls:1.23%
cases:2.67%
controls:0.73%
—
—
—
—
cases:0.90%
controls:0.36%
cases:2.91%
controls:0.90%
cases:7.66%
controls:3.06%
17
82
656
6609
18
49
657
6657
—
—
6
24
660
6671
18
59
601
6487
41
175
494
5542
potassium chloride; oral
A12BA01 [21600877]
1.5e-01
7.1e-01
1.7e+00
—
1.3e+00
9.6e-01
8.3e-01
cases:1.93%
controls:1.67%
cases:2.81%
controls:1.40%
cases:1.48%
controls:0.28%
—
—
cases:1.35%
controls:0.37%
cases:3.72%
controls:1.45%
cases:6.36%
controls:2.87%
13
112
660
6579
19
94
656
6612
10
19
665
6687
—
9
25
657
6670
23
95
596
6451
34
164
501
5553
Thorax X-ray examination
GD1AA [2001303617]
3.6e-01
6.0e-01
1.5e+00
1.0e+50
1.3e+00
6.7e-01
3.0e-01
cases:9.21%
controls:6.61%
cases:5.04%
controls:2.83%
cases:1.78%
controls:0.39%
cases:1.33%
controls:0.00%
cases:1.80%
controls:0.52%
cases:5.33%
controls:2.81%
cases:10.84%
controls:8.27%
62
442
611
6249
34
190
641
6516
12
26
663
6680
9
0
666
6706
12
35
654
6660
33
184
586
6362
58
473
477
5244
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
9.4e-02
6.1e-01
1.9e+00
—
1.5e+00
4.6e-01
4.9e-01
cases:4.90%
controls:4.48%
cases:3.85%
controls:2.13%
cases:1.78%
controls:0.28%
—
—
cases:1.80%
controls:0.39%
cases:3.55%
controls:2.28%
cases:11.03%
controls:7.07%
33
300
640
6391
26
143
649
6563
12
19
663
6687
—
12
26
654
6669
22
149
597
6397
59
404
476
5313
Nausea and vomiting
R11 [45539317]
8.1e-01
1.7e+00
—
—
—
1.7e+00
6.6e-01
cases:1.63%
controls:0.73%
cases:1.78%
controls:0.33%
—
—
—
—
—
—
cases:1.78%
controls:0.34%
cases:2.62%
controls:1.36%
11
49
662
6642
12
22
663
6684
—
—
—
11
22
608
6524
14
78
521
5639
levodopa and decarboxylase inhibitor; oral
N04BA02 [21604465]
1.2e+00
1.1e+00
—
—
—
9.6e-01
1.0e+00
cases:2.23%
controls:0.69%
cases:1.93%
controls:0.63%
—
—
—
—
—
—
cases:1.94%
controls:0.75%
cases:3.18%
controls:1.14%
15
46
658
6645
13
42
662
6664
—
—
—
12
49
607
6497
17
65
518
5652
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
1.2e+00
3.3e+00
—
—
—
—
1.3e+00
cases:0.89%
controls:0.27%
cases:1.93%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.26%
6
18
667
6673
13
5
662
6701
—
—
—
—
5
15
530
5702
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
2.8e-01
1.1e+00
9.6e-01
—
—
1.1e+00
9.9e-01
cases:2.08%
controls:1.58%
cases:2.22%
controls:0.73%
cases:0.89%
controls:0.34%
—
—
—
—
cases:2.58%
controls:0.89%
cases:6.73%
controls:2.61%
14
106
659
6585
15
49
660
6657
6
23
669
6683
—
—
16
58
603
6488
36
149
499
5568
No procedures
SPAT1301 [2001700402]
5.1e-01
8.8e-01
1.2e+00
—
6.4e-01
1.0e+00
8.0e-01
cases:8.17%
controls:5.08%
cases:4.59%
controls:1.95%
cases:1.63%
controls:0.48%
—
—
cases:0.90%
controls:0.48%
cases:5.17%
controls:1.96%
cases:12.71%
controls:6.16%
55
340
618
6351
31
131
644
6575
11
32
664
6674
—
6
32
660
6663
32
128
587
6418
68
352
467
5365
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
3.3e-01
6.4e-01
2.6e+00
—
1.5e+00
1.3e-02
5.9e-01
cases:4.90%
controls:3.59%
cases:2.52%
controls:1.34%
cases:1.19%
controls:0.09%
—
—
cases:0.75%
controls:0.16%
cases:1.45%
controls:1.44%
cases:9.16%
controls:5.28%
33
240
640
6451
17
90
658
6616
8
6
667
6700
—
5
11
661
6684
9
94
610
6452
49
302
486
5415
Parkinson disease
G20 [45538098]
9.2e-01
1.3e+00
1.5e+00
—
1.9e+00
1.1e+00
8.1e-01
cases:1.78%
controls:0.72%
cases:2.07%
controls:0.57%
cases:0.89%
controls:0.19%
—
—
cases:1.05%
controls:0.16%
cases:1.62%
controls:0.57%
cases:2.24%
controls:1.01%
12
48
661
6643
14
38
661
6668
6
13
669
6693
—
7
11
659
6684
10
37
609
6509
12
58
523
5659
clonazepam; oral, parenteral
N03AE01 [21604415]
1.0e+00
1.1e+00
1.3e+00
—
—
1.1e+00
8.0e-01
cases:2.97%
controls:1.09%
cases:2.07%
controls:0.72%
cases:0.74%
controls:0.21%
—
—
—
—
cases:2.10%
controls:0.73%
cases:2.43%
controls:1.10%
20
73
653
6618
14
48
661
6658
5
14
670
6692
—
—
13
48
606
6498
13
63
522
5654
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
1.4e+00
1.7e+00
—
—
—
1.4e+00
1.4e+00
cases:1.34%
controls:0.34%
cases:1.33%
controls:0.24%
—
—
—
—
—
—
cases:0.97%
controls:0.24%
cases:2.06%
controls:0.51%
9
23
664
6668
9
16
666
6690
—
—
—
6
16
613
6530
11
29
524
5688
More than three and less than five hours
ZXE20 [2001311408]
7.1e-02
1.6e+00
—
1.0e+50
—
1.0e+00
1.5e+00
cases:1.63%
controls:1.52%
cases:1.78%
controls:0.36%
—
—
cases:1.04%
controls:0.00%
—
—
cases:0.97%
controls:0.35%
cases:4.30%
controls:0.98%
11
102
662
6589
12
24
663
6682
—
7
0
668
6706
—
6
23
613
6523
23
56
512
5661
Concussion
S06.0 [45582805]
7.7e-01
2.0e+00
—
1.0e+50
—
1.6e+00
1.1e+00
cases:1.63%
controls:0.76%
cases:1.93%
controls:0.27%
—
—
cases:0.89%
controls:0.00%
—
—
cases:1.13%
controls:0.23%
cases:4.11%
controls:1.43%
11
51
662
6640
13
18
662
6688
—
6
0
669
6706
—
7
15
612
6531
22
82
513
5635
Weakness/tiredness general
A04 [2002000145]
6.9e-01
1.0e+00
—
—
2.3e+00
8.2e-01
7.5e-01
cases:2.23%
controls:1.14%
cases:1.48%
controls:0.55%
—
—
—
—
cases:0.90%
controls:0.09%
cases:0.97%
controls:0.43%
cases:5.23%
controls:2.55%
15
76
658
6615
10
37
665
6669
—
—
6
6
660
6689
6
28
613
6518
28
146
507
5571
Complex partial seizures with only alteration of consciousness
G40.20 [2000502139]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.10%
—
—
—
—
—
—
11
6
524
5711
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.4e-01
4.7e-01
1.2e+00
—
1.7e+00
1.1e-01
7.4e-02
cases:6.39%
controls:5.11%
cases:4.89%
controls:3.12%
cases:1.78%
controls:0.52%
—
—
cases:3.45%
controls:0.63%
cases:3.55%
controls:3.19%
cases:7.48%
controls:6.98%
43
342
630
6349
33
209
642
6497
12
35
663
6671
—
23
42
643
6653
22
209
597
6337
40
399
495
5318
Microorganisms panel - Urine sediment
58435-9 [40761536]
3.2e-01
1.1e+00
—
1.0e+50
2.0e+00
7.8e-01
9.9e-01
cases:2.08%
controls:1.52%
cases:1.78%
controls:0.60%
—
—
cases:0.89%
controls:0.00%
cases:1.05%
controls:0.15%
cases:1.62%
controls:0.75%
cases:4.30%
controls:1.64%
14
102
659
6589
12
40
663
6666
—
6
0
669
6706
7
10
659
6685
10
49
609
6497
23
94
512
5623
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
1.7e-01
3.0e-01
1.4e+00
—
1.5e+00
1.7e-01
-3.1e-02
cases:7.73%
controls:6.58%
cases:5.33%
controls:4.00%
cases:2.37%
controls:0.60%
—
—
cases:3.00%
controls:0.66%
cases:5.17%
controls:4.40%
cases:11.03%
controls:11.33%
52
440
621
6251
36
268
639
6438
16
40
659
6666
—
20
44
646
6651
32
288
587
6258
59
648
476
5069
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
1.0e+00
1.8e+00
—
—
—
—
8.3e-01
cases:2.23%
controls:0.79%
cases:2.07%
controls:0.34%
—
—
—
—
—
—
—
—
cases:2.99%
controls:1.33%
15
53
658
6638
14
23
661
6683
—
—
—
—
16
76
519
5641
MRI examination of brain with 3 Tesla magnet
AA1BM [2001300113]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.50%
controls:0.09%
—
—
—
—
—
—
8
5
527
5712
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.1e-01
4.4e-01
1.2e+00
—
1.7e+00
2.6e-01
2.1e-01
cases:7.28%
controls:6.55%
cases:7.70%
controls:5.11%
cases:4.00%
controls:1.24%
—
—
cases:5.86%
controls:1.18%
cases:7.59%
controls:5.96%
cases:13.27%
controls:11.05%
49
438
624
6253
52
343
623
6363
27
83
648
6623
—
39
79
627
6616
47
390
572
6156
71
632
464
5085
Sequelae of intracerebral haemorrhage
I69.1 [45538404]
2.3e+00
—
—
—
—
—
2.8e+00
cases:0.74%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.12%
5
5
668
6686
—
—
—
—
—
11
7
524
5710
Neurological sympt/complt other
N29 [2002000734]
1.6e+00
—
—
—
—
—
2.8e+00
cases:0.89%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.14%
6
12
667
6679
—
—
—
—
—
12
8
523
5709
phenytoin; oral, parenteral
N03AB02 [21604399]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.10%
—
—
—
—
—
—
9
6
526
5711
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
-2.0e-01
—
—
—
2.8e+00
7.2e-01
-2.9e-01
cases:1.19%
controls:1.45%
—
—
—
—
—
—
cases:1.20%
controls:0.07%
cases:0.97%
controls:0.47%
cases:1.31%
controls:1.75%
8
97
665
6594
—
—
—
8
5
658
6690
6
31
613
6515
7
100
528
5617
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.5e+00
—
—
1.0e+50
—
2.8e+00
1.5e+00
cases:0.89%
controls:0.19%
—
—
—
—
cases:0.74%
controls:0.00%
—
—
cases:1.45%
controls:0.09%
cases:1.12%
controls:0.24%
6
13
667
6678
—
—
5
0
670
6706
—
9
6
610
6540
6
14
529
5703
Specialised imaging for glaucoma
CS5Z4 [2001301479]
—
—
—
—
—
2.8e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.45%
controls:0.09%
cases:1.31%
controls:0.35%
—
—
—
—
—
9
6
610
6540
7
20
528
5697
Monitoring of emergency patient
SPAT1104 [2001700205]
6.6e-01
2.8e+00
—
—
—
1.5e+00
7.7e-01
cases:1.49%
controls:0.78%
cases:1.63%
controls:0.10%
—
—
—
—
—
—
cases:0.81%
controls:0.18%
cases:1.31%
controls:0.61%
10
52
663
6639
11
7
664
6699
—
—
—
5
12
614
6534
7
35
528
5682
Other specified counselling
Z71.8 [45581061]
3.5e-01
6.2e-01
—
—
1.8e+00
9.8e-01
4.0e-01
cases:4.01%
controls:2.87%
cases:2.81%
controls:1.54%
—
—
—
—
cases:1.20%
controls:0.21%
cases:4.04%
controls:1.56%
cases:8.22%
controls:5.68%
27
192
646
6499
19
103
656
6603
—
—
8
14
658
6681
25
102
594
6444
44
325
491
5392
Visual field defects
H53.4 [45557469]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.16%
—
—
—
—
—
—
12
9
523
5708
Basophils [#/volume] in Blood
26444-0 [3006315]
6.9e-02
3.2e-01
1.2e+00
—
1.5e+00
1.7e-01
1.6e-01
cases:8.47%
controls:7.95%
cases:6.37%
controls:4.71%
cases:2.81%
controls:0.88%
—
—
cases:4.20%
controls:0.99%
cases:5.98%
controls:5.10%
cases:13.64%
controls:11.91%
57
532
616
6159
43
316
632
6390
19
59
656
6647
—
28
66
638
6629
37
334
582
6212
73
681
462
5036
Pneumonia, unspecified
J18.9 [45601123]
3.6e-01
7.4e-01
—
—
2.1e+00
5.0e-01
6.1e-01
cases:4.01%
controls:2.82%
cases:2.52%
controls:1.22%
—
—
—
—
cases:1.95%
controls:0.25%
cases:2.75%
controls:1.68%
cases:8.60%
controls:4.88%
27
189
646
6502
17
82
658
6624
—
—
13
17
653
6678
17
110
602
6436
46
279
489
5438
Implementation of occupational therapy rehabilitation plan
SPAT1226 [2001700327]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.43%
controls:0.17%
—
—
—
—
—
—
13
10
522
5707
Monocytes [#/volume] in Blood
26484-6 [3001604]
7.3e-02
3.3e-01
1.2e+00
—
1.5e+00
1.7e-01
1.6e-01
cases:8.47%
controls:7.92%
cases:6.37%
controls:4.68%
cases:2.81%
controls:0.88%
—
—
cases:4.20%
controls:1.00%
cases:5.98%
controls:5.09%
cases:13.64%
controls:11.91%
57
530
616
6161
43
314
632
6392
19
59
656
6647
—
28
67
638
6628
37
333
582
6213
73
681
462
5036
Extirpation of intracranial lesion
AAB00 [2001300256]
2.6e+00
—
—
—
—
—
—
cases:1.04%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
7
5
666
6686
—
—
—
—
—
—
CT of cerebral ischaemia
AA5BD [2001300158]
—
2.6e+00
—
1.0e+50
—
—
—
—
—
cases:1.04%
controls:0.07%
—
—
cases:1.19%
controls:0.00%
—
—
—
—
—
—
—
7
5
668
6701
—
8
0
667
6706
—
—
—
Otolaryngology
4 [38004449]
2.8e-01
6.6e-01
9.2e-01
—
1.3e+00
6.9e-01
1.1e-01
cases:15.01%
controls:11.81%
cases:7.85%
controls:4.24%
cases:2.07%
controls:0.84%
—
—
cases:2.25%
controls:0.64%
cases:8.40%
controls:4.40%
cases:13.46%
controls:12.17%
101
790
572
5901
53
284
622
6422
14
56
661
6650
—
15
43
651
6652
52
288
567
6258
72
696
463
5021
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
-3.0e-01
—
—
—
2.6e+00
—
2.6e-01
cases:0.89%
controls:1.20%
—
—
—
—
—
—
cases:1.20%
controls:0.09%
—
—
cases:1.87%
controls:1.45%
6
80
667
6611
—
—
—
8
6
658
6689
—
10
83
525
5634
Eosinophils [#/volume] in Blood
26449-9 [3013115]
2.1e-02
3.0e-01
1.1e+00
—
1.5e+00
1.4e-01
1.4e-01
cases:8.47%
controls:8.31%
cases:6.52%
controls:4.92%
cases:2.81%
controls:0.94%
—
—
cases:4.35%
controls:1.03%
cases:5.98%
controls:5.22%
cases:13.83%
controls:12.21%
57
556
616
6135
44
330
631
6376
19
63
656
6643
—
29
69
637
6626
37
342
582
6204
74
698
461
5019
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
1.5e-01
3.8e-01
1.2e+00
—
1.4e+00
1.0e-01
2.0e-01
cases:17.24%
controls:15.18%
cases:12.15%
controls:8.62%
cases:3.26%
controls:0.98%
—
—
cases:3.45%
controls:0.91%
cases:9.37%
controls:8.54%
cases:26.17%
controls:22.53%
116
1016
557
5675
82
578
593
6128
22
66
653
6640
—
23
61
643
6634
58
559
561
5987
140
1288
395
4429
Basophils/Leukocytes in Blood
30180-4 [3022096]
-1.1e-01
2.0e-01
1.1e+00
—
1.5e+00
5.9e-02
-5.2e-02
cases:6.84%
controls:7.55%
cases:5.48%
controls:4.55%
cases:2.52%
controls:0.85%
—
—
cases:3.90%
controls:0.93%
cases:5.01%
controls:4.74%
cases:10.47%
controls:10.97%
46
505
627
6186
37
305
638
6401
17
57
658
6649
—
26
62
640
6633
31
310
588
6236
56
627
479
5090
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-6.1e-02
2.0e-01
1.1e+00
—
1.5e+00
2.4e-02
-1.3e-02
cases:7.13%
controls:7.55%
cases:5.48%
controls:4.55%
cases:2.52%
controls:0.85%
—
—
cases:3.90%
controls:0.93%
cases:4.85%
controls:4.74%
cases:10.84%
controls:10.97%
48
505
625
6186
37
305
638
6401
17
57
658
6649
—
26
62
640
6633
30
310
589
6236
58
627
477
5090
Treatment plan or consultation
WZC00 [2001310885]
2.7e-01
7.3e-01
—
—
1.8e+00
3.3e-01
5.5e-02
cases:5.50%
controls:4.24%
cases:4.00%
controls:1.97%
—
—
—
—
cases:1.20%
controls:0.19%
cases:2.58%
controls:1.86%
cases:6.36%
controls:6.03%
37
284
636
6407
27
132
648
6574
—
—
8
13
658
6682
16
122
603
6424
34
345
501
5372
Neurological disease other
N99 [2002000796]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.09%
—
—
—
—
—
—
6
5
529
5712
Nontraumatic subdural haemorrhage
I62.0 [45605804]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.09%
—
—
—
—
—
—
6
5
529
5712
Sodium [Moles/volume] in Urine
2955-3 [3003181]
—
2.6e+00
—
—
—
—
—
—
—
cases:1.33%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
9
7
666
6699
—
—
—
—
—
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-4.1e-02
2.0e-01
1.1e+00
—
1.5e+00
5.5e-02
-1.7e-02
cases:7.28%
controls:7.56%
cases:5.48%
controls:4.52%
cases:2.52%
controls:0.85%
—
—
cases:3.90%
controls:0.94%
cases:5.01%
controls:4.75%
cases:10.84%
controls:11.00%
49
506
624
6185
37
303
638
6403
17
57
658
6649
—
26
63
640
6632
31
311
588
6235
58
629
477
5088
risperidone; oral, parenteral
N05AX08 [21604559]
5.5e-01
6.1e-01
7.7e-01
—
—
1.2e+00
1.3e+00
cases:1.49%
controls:0.87%
cases:1.33%
controls:0.73%
cases:0.74%
controls:0.34%
—
—
—
—
cases:2.91%
controls:0.89%
cases:5.61%
controls:1.52%
10
58
663
6633
9
49
666
6657
5
23
670
6683
—
—
18
58
601
6488
30
87
505
5630
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
6.1e-02
3.3e-01
1.1e+00
—
1.4e+00
1.4e-01
1.2e-01
cases:8.77%
controls:8.29%
cases:6.67%
controls:4.88%
cases:2.81%
controls:0.94%
—
—
cases:4.20%
controls:1.05%
cases:5.98%
controls:5.24%
cases:13.83%
controls:12.42%
59
555
614
6136
45
327
630
6379
19
63
656
6643
—
28
70
638
6625
37
343
582
6203
74
710
461
5007
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
2.2e-01
5.7e-01
1.8e+00
—
1.5e+00
1.8e-01
7.1e-01
cases:2.67%
controls:2.15%
cases:2.67%
controls:1.52%
cases:1.19%
controls:0.19%
—
—
cases:0.90%
controls:0.19%
cases:1.62%
controls:1.36%
cases:7.66%
controls:3.92%
18
144
655
6547
18
102
657
6604
8
13
667
6693
—
6
13
660
6682
10
89
609
6457
41
224
494
5493
Intracerebral haemorrhage in hemisphere, subcortical
I61.0 [45605803]
—
—
—
1.0e+50
—
2.5e+00
—
—
—
—
—
—
—
cases:0.74%
controls:0.00%
—
—
cases:1.13%
controls:0.09%
—
—
—
—
—
5
0
670
6706
—
7
6
612
6540
—
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-4.2e-02
2.1e-01
1.1e+00
—
1.4e+00
6.5e-02
-4.8e-02
cases:7.58%
controls:7.88%
cases:5.63%
controls:4.61%
cases:2.52%
controls:0.84%
—
—
cases:3.90%
controls:1.00%
cases:5.17%
controls:4.86%
cases:11.03%
controls:11.51%
51
527
622
6164
38
309
637
6397
17
56
658
6650
—
26
67
640
6628
32
318
587
6228
59
658
476
5059
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66885-5 [40769539]
—
1.7e+00
—
—
—
2.5e+00
—
—
—
cases:0.89%
controls:0.16%
—
—
—
—
—
—
cases:1.29%
controls:0.11%
—
—
—
6
11
669
6695
—
—
—
8
7
611
6539
—
X-ray examination of the lungs in one projection
GD1PA [2001303645]
1.1e+00
1.4e+00
—
—
—
1.5e+00
1.1e+00
cases:1.78%
controls:0.60%
cases:1.48%
controls:0.37%
—
—
—
—
—
—
cases:1.13%
controls:0.26%
cases:3.93%
controls:1.33%
12
40
661
6651
10
25
665
6681
—
—
—
7
17
612
6529
21
76
514
5641
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-1.9e-02
4.3e-01
1.2e+00
—
1.3e+00
9.0e-02
1.2e-01
cases:14.12%
controls:14.35%
cases:10.81%
controls:7.32%
cases:2.67%
controls:0.82%
—
—
cases:3.30%
controls:0.93%
cases:7.75%
controls:7.13%
cases:22.06%
controls:20.05%
95
960
578
5731
73
491
602
6215
18
55
657
6651
—
22
62
644
6633
48
467
571
6079
118
1146
417
4571
Benign neoplasm: Pituitary gland
D35.2 [45581304]
—
2.5e+00
—
—
—
—
-1.0e+50
—
—
cases:0.89%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
6
5
669
6701
—
—
—
—
0
6
535
5711
donepezil; oral
N06DA02 [21604795]
2.4e-01
1.0e+00
1.2e+00
—
—
1.5e+00
9.3e-01
cases:0.89%
controls:0.70%
cases:1.78%
controls:0.64%
cases:1.19%
controls:0.34%
—
—
—
—
cases:3.23%
controls:0.72%
cases:3.74%
controls:1.50%
6
47
667
6644
12
43
663
6663
8
23
667
6683
—
—
20
47
599
6499
20
86
515
5631
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-6.1e-02
1.8e-01
1.1e+00
—
1.4e+00
-2.4e-02
-5.9e-02
cases:7.13%
controls:7.55%
cases:5.33%
controls:4.47%
cases:2.52%
controls:0.85%
—
—
cases:3.45%
controls:0.91%
cases:4.52%
controls:4.63%
cases:10.65%
controls:11.23%
48
505
625
6186
36
300
639
6406
17
57
658
6649
—
23
61
643
6634
28
303
591
6243
57
642
478
5075
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41602-4 [3033386]
2.5e+00
1.0e+50
—
—
1.0e+50
1.0e+50
—
cases:1.04%
controls:0.09%
cases:1.63%
controls:0.00%
—
—
—
—
cases:3.30%
controls:0.00%
cases:1.94%
controls:0.00%
—
—
7
6
666
6685
11
0
664
6706
—
—
22
0
644
6695
12
0
607
6546
—
Extensive CT angiography of brain
PA2BD [2001300226]
2.5e+00
—
—
—
—
—
—
cases:1.04%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
666
6685
—
—
—
—
—
—
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
—
1.1e+00
2.5e+00
—
1.8e+00
8.9e-01
7.0e-01
—
—
cases:1.63%
controls:0.57%
cases:1.04%
controls:0.09%
—
—
cases:0.75%
controls:0.12%
cases:1.62%
controls:0.67%
cases:4.49%
controls:2.27%
—
11
38
664
6668
7
6
668
6700
—
5
8
661
6687
10
44
609
6502
24
130
511
5587
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
—
2.5e+00
—
—
—
—
5.3e-01
—
—
cases:1.04%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.66%
—
7
6
668
6700
—
—
—
—
6
38
529
5679
Unspecified dementia
F03 [45566772]
1.2e+00
2.5e+00
—
—
—
1.6e+00
1.1e+00
cases:1.04%
controls:0.33%
cases:2.37%
controls:0.21%
—
—
—
—
—
—
cases:1.13%
controls:0.23%
cases:2.43%
controls:0.86%
7
22
666
6669
16
14
659
6692
—
—
—
7
15
612
6531
13
49
522
5668

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
227
129
25.27
292.96
3.0
1.3
24.03
12.98
e6/l
0.59
183
86
227
131
24.88
290.86
3.0
1.3
1188.05
1086.19
e6/l
0.04
192
91
230
147
22.55
280.60
2.5
1.3
494.50
515.75
mg/l
0.16
225
140
189
116
21.76
233.23
3.0
1.3
—
—
—
0
0
125
57
26.34
173.76
2.6
1.4
—
—
—
0
0
78
66
13.14
78.48
2.9
1.5
—
—
—
0
0
56
42
14.38
60.25
1.1
1.0
553.00
600.60
ng/l
0.20
28
30
56
42
14.38
60.25
1.1
1.0
231.42
320.50
ng/l
1.29
24
30
59
94
6.75
36.02
5.4
5.5
11.18
11.70
mg/l
0.31
54
87
323
1987
2.14
21.44
3.0
2.2
157.33
287.52
u/l
1.76
308
1885
164
765
2.48
21.11
10.5
8.3
7.43
7.42
ph
0.93
114
445
162
759
2.46
20.61
10.5
8.3
1.70
1.08
mmol/l
1.66
137
628
327
2047
2.10
20.46
5.4
3.4
—
—
—
0
0
300
1821
2.11
20.35
5.8
4.4
—
—
—
0
0
102
404
2.78
18.14
10.5
5.8
—
—
—
0
0
494
3708
2.06
17.66
9.3
5.4
6.63
6.65
mmol/l
0.12
486
3530
418
3016
1.92
16.04
13.4
15.8
1.17
1.28
inr
5.47
379
2529
50
142
3.71
15.42
1.8
1.5
85.23
62.24
mmol/l
2.33
44
121
410
2971
1.89
15.19
10.3
6.9
1.20
1.21
mmol/l
3.48
387
2741
350
2457
1.83
13.91
4.5
4.0
63.41
76.31
ng/l
0.13
276
1815
432
3285
1.79
12.67
10.2
7.3
1.21
1.21
mmol/l
0.50
368
2841
182
1064
1.95
12.63
3.7
3.5
0.83
0.81
mmol/l
1.77
169
999
277
1852
1.81
12.60
6.8
4.1
0.00
0.00
estimate
0.74
100
644
32
79
4.19
11.96
2.0
1.4
289.59
275.02
mosm/kgh2o
2.65
27
58
154
900
1.91
10.50
8.7
6.8
105.42
104.27
mmol/l
2.35
154
900
200
1275
1.79
10.30
4.0
3.0
504.71
524.04
mosm/kgh2o
0.64
182
1120
87
422
2.21
9.84
10.7
9.6
95.22
93.93
%
1.80
87
417
220
1479
1.70
9.24
3.9
2.8
6.65
5.66
e6/l
0.50
210
1354
494
4084
1.67
9.06
8.0
5.0
4602.08
2046.50
e6/l
0.49
12
76
230
1574
1.68
8.99
4.9
4.1
90.50
88.58
%
0.60
223
1543
54
223
2.54
8.77
9.6
3.9
1.46
1.36
mmol/l
0.20
54
217
275
1988
1.62
8.58
3.0
2.5
—
—
—
0
0
346
2646
1.59
8.52
5.0
3.7
6.57
6.23
ph
7.07
215
1492
328
2478
1.60
8.50
6.8
4.1
0.02
0.03
estimate
0.12
81
571
146
901
1.78
8.20
5.8
5.7
1.00
1.07
mmol/l
2.53
136
830
124
732
1.84
8.05
5.0
4.5
7.38
7.38
ph
0.01
70
437
287
2126
1.58
7.93
4.6
3.6
66.12
88.43
e6/l
0.24
245
1642
123
731
1.82
7.81
4.9
4.3
5.93
5.76
kpa
0.77
118
709
216
1503
1.63
7.71
6.6
4.3
1.02
1.02
kg/l
0.13
162
1020
173
1141
1.68
7.61
1.9
1.8
1348.91
1175.66
nmol/l
2.03
144
851
147
929
1.73
7.56
2.3
2.0
—
—
—
0
0
29
94
3.17
7.36
1.4
1.5
—
—
—
0
0
29
94
3.17
7.36
1.4
1.5
—
—
—
0
0
29
94
3.17
7.36
1.4
1.5
—
—
—
0
0
29
94
3.17
7.36
1.4
1.5
—
—
—
0
0
117
703
1.79
7.14
5.1
4.4
1.71
1.71
mmol/l
0.00
105
589
91
508
1.91
7.01
6.4
4.0
1.22
1.22
mmol/l
0.49
82
438
266
1991
1.53
6.76
4.5
4.1
7.40
7.40
ph
1.91
207
1435
402
3294
1.50
6.56
6.5
4.2
11.54
4.94
estimate
0.23
116
709
36
143
2.60
6.37
5.4
3.4
—
—
—
0
0
58
287
2.11
6.25
3.0
1.8
0.82
2.17
ug/l
0.73
50
254
351
2818
1.48
6.20
3.6
2.8
—
—
estimate
—
0
0
189
1335
1.56
6.14
1.8
1.8
478.70
10598265.57
pmol/l
0.50
157
1104
16
30
5.43
5.87
3.2
2.4
64.50
44.25
umol/l
1.59
16
25
261
1995
1.48
5.80
2.8
2.6
52.14
62.31
u/l
1.92
242
1855
394
3266
1.46
5.74
6.5
4.1
0.00
0.00
estimate
-0.00
110
686
522
5765
0.65
5.72
5.4
5.9
2.65
2.65
mmol/l
0.00
484
5321
349
2830
1.45
5.69
6.3
5.0
34.56
35.56
g/l
2.71
319
2642
119
765
1.67
5.66
2.4
1.7
—
—
—
0
0
32
129
2.55
5.52
5.9
3.6
1.92
2.71
mmol/l
1.14
24
87
18
52
3.52
5.48
1.4
1.4
0.64
0.98
promille
0.49
12
41
397
3322
1.44
5.33
6.6
4.2
0.00
0.46
estimate
0.51
106
663
300
2386
1.44
5.31
5.5
4.3
129.99
130.19
e6/l
0.00
244
1709
510
5634
0.67
5.22
4.7
5.1
1.39
1.47
mmol/l
3.76
469
5191
23
563
0.39
5.06
1.2
1.5
—
—
—
0
0
395
3333
1.41
4.88
6.4
6.5
10.04
12.12
umol/l
2.85
375
3173
515
5661
0.68
4.88
4.8
5.2
4.51
4.58
mmol/l
0.77
473
5251
158
2113
0.68
4.47
3.5
3.2
—
—
—
0
0
277
2236
1.39
4.27
3.6
3.3
2.35
2.36
mmol/l
0.17
252
2022
233
1832
1.40
4.18
4.5
3.5
0.52
0.43
e6/l
0.22
196
1360
195
2475
0.71
4.03
1.9
2.0
1.68
1.34
mmol/l
1.01
160
2062
12
28
4.34
3.83
1.1
1.0
1667.33
1396.18
miu/ml
0.30
12
28
492
5386
0.73
3.76
4.1
4.3
1.38
1.27
mmol/l
1.82
448
4922
77
493
1.63
3.72
7.3
4.0
—
—
—
0
0
95
640
1.56
3.72
2.6
2.1
373.84
389.10
nmol/l
0.30
87
600
13
34
3.87
3.70
10.7
12.9
648.77
839.00
nmol/l
0.79
13
34
91
616
1.55
3.49
9.3
8.5
—
—
—
0
0
17
402
0.41
3.49
1.6
1.8
3.31
3.45
mmol/l
0.18
11
290
7
224
0.31
3.37
1.1
1.6
—
—
—
0
0
521
5612
0.74
3.15
5.0
5.3
5.96
5.96
mmol/l
0.02
474
5119
41
231
1.82
3.15
2.1
2.6
20.12
21.08
s
0.89
34
216
190
2346
0.74
3.10
2.0
2.2
—
—
—
0
0
508
5483
0.75
3.02
6.5
6.6
39.39
39.44
mmol/mol
0.04
474
5107
6
9
6.71
2.87
2.3
1.0
—
—
—
0
0
5
6
8.38
2.75
2.8
5.7
—
—
—
0
0
6
10
6.04
2.70
1.3
2.1
19.02
14.69
umol/l
—
6
10
78
543
1.49
2.66
2.2
2.5
5.83
7.12
ug/l
0.17
64
480
42
254
1.69
2.58
10.8
4.3
8.72
8.46
kpa
0.48
42
247
12
279
0.42
2.43
1.0
1.1
—
—
—
0
0
6
12
5.03
2.40
1.2
1.5
—
—
—
0
0
13
52
2.53
2.37
1.8
2.3
1.88
2.50
u/field
—
8
26
213
1777
1.28
2.36
6.6
3.6
0.01
0.06
estimate
0.44
87
544
228
1921
1.27
2.33
1.9
1.7
19.65
20.55
nmol/l
0.32
204
1604
15
66
2.30
2.25
1.6
1.3
—
—
—
0
0
22
114
1.96
2.22
7.1
2.7
9.00
8.32
pmol/l
0.15
22
114
37
226
1.67
2.22
1.6
1.5
31.02
25.33
iu/l
0.39
31
186
79
1067
0.71
2.22
2.5
3.1
0.78
0.80
ug/l
0.05
55
698
164
1333
1.30
2.21
3.1
2.9
2.47
2.46
mmol/l
0.67
150
1191
9
30
3.03
2.15
1.3
1.2
—
—
—
0
0
18
88
2.07
2.13
2.3
2.2
—
—
—
0
0
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
5
11
4.57
1.94
4.6
1.0
—
—
—
0
0
15
71
2.14
1.93
1.7
1.5
0.28
0.37
nmol/l
—
10
53
158
1303
1.27
1.89
4.2
4.3
331.98
406.71
ng/l
0.15
120
1050
49
698
0.68
1.86
1.3
1.3
—
—
—
0
0
7
165
0.42
1.81
1.3
1.1
1.54
1.54
g/l
—
7
165
32
495
0.63
1.81
1.2
1.2
—
—
—
0
0
62
837
0.72
1.75
1.3
1.2
—
—
—
0
0
188
1603
1.23
1.68
1.4
1.4
—
—
—
0
0
78
597
1.34
1.62
1.7
2.2
0.00
0.00
estimate
-0.00
20
117
495
4644
1.21
1.60
8.5
8.2
83.41
81.10
u/l
0.40
473
4385
269
3006
0.83
1.60
7.7
6.2
57.94
57.28
%
0.36
261
2869
6
20
3.02
1.58
1.2
1.2
—
—
—
0
0
13
64
2.05
1.55
2.8
2.9
12.13
12.12
index
—
8
43
81
1028
0.76
1.53
1.3
1.3
7.17
11.42
u/ml
0.56
39
366
67
506
1.36
1.53
8.3
4.6
7.40
7.42
ph
1.94
57
415
34
226
1.53
1.52
1.8
2.1
200.82
508.99
ug/l
0.89
28
211
8
170
0.46
1.48
1.4
1.1
0.85
0.90
g/l
—
8
170
44
313
1.43
1.43
1.6
2.1
0.05
0.00
estimate
0.48
19
91
9
41
2.21
1.37
1.9
3.5
15.87
15.70
%
—
9
41
34
482
0.69
1.31
2.3
2.5
13.99
13.27
nmol/l
0.21
28
436
5
18
2.79
1.28
4.2
1.8
40.20
29.17
%
—
5
18
76
602
1.29
1.28
2.1
2.7
70.13
69.70
e9/l
0.04
61
450
593
6129
0.81
1.27
13.1
12.3
27.72
25.56
u/l
0.95
574
5959
97
793
1.26
1.27
2.1
2.8
1.71
1.80
%
0.49
88
715
34
237
1.46
1.25
2.5
3.6
361.42
273.29
mg/l
0.23
19
95
608
5874
1.23
1.20
28.6
16.8
25.09
24.78
mg/l
0.09
548
4851
194
1711
1.18
1.20
2.7
2.3
3.43
2.98
mg/l
1.22
170
1465
17
271
0.62
1.16
1.1
1.4
—
15.90
—
0
6
15
87
1.74
1.16
1.3
1.3
27.86
26.11
ng/l
0.11
15
87
64
802
0.78
1.13
2.2
2.4
284.19
129.86
ug/g
0.57
48
627
23
151
1.54
1.13
2.2
2.0
3925.52
7179.41
u/l
—
6
53
11
58
1.91
1.12
3.2
1.3
—
—
—
0
0
66
524
1.29
1.11
1.5
1.4
—
—
—
0
0
94
1124
0.81
1.10
1.3
1.3
31.85
34.40
iu/ml
0.08
33
353
62
777
0.78
1.10
1.2
1.3
—
—
—
0
0
619
6007
1.22
1.07
31.9
20.4
3.95
3.99
mmol/l
3.03
607
5881
109
1276
0.83
1.04
2.5
1.6
2.21
2.42
g/l
0.60
73
752
618
6000
1.22
1.04
32.9
20.3
139.63
139.65
mmol/l
0.05
607
5885
69
847
0.79
1.03
1.3
1.4
738.46
506.09
titre
0.26
13
184
5
22
2.28
1.03
2.0
2.3
0.54
0.49
e9/l
—
5
5
11
60
1.85
1.03
3.1
2.1
1446.73
1227.81
e6/l
0.33
11
47
14
226
0.61
1.02
1.1
1.3
—
—
—
0
0
12
68
1.78
1.01
1.2
1.2
—
—
—
0
0
7
35
2.01
1.00
2.3
1.5
129.86
164.45
mmol/24h
—
7
35
19
284
0.66
1.00
1.1
1.2
—
—
—
0
0
26
181
1.45
0.99
13.1
11.8
—
—
—
0
0
69
560
1.26
0.99
3.4
3.1
66.29
66.37
g/l
0.03
63
515
9
50
1.81
0.97
3.3
2.0
36.10
40.17
%
—
9
50
44
564
0.77
0.94
1.6
1.5
—
—
—
0
0
28
384
0.72
0.94
1.3
1.3
—
—
—
0
0
183
2029
0.87
0.90
3.5
3.5
52.02
51.57
mg/l
0.01
125
1311
14
218
0.64
0.90
1.1
1.1
—
—
—
0
0
8
43
1.87
0.87
2.6
2.6
0.50
0.81
index
—
8
43
6
30
2.01
0.87
2.5
2.2
132.82
69.20
ug/l
—
6
30
278
2992
0.88
0.87
7.7
6.4
0.60
0.68
%
1.57
266
2805
278
2992
0.88
0.87
7.7
6.3
2.53
2.88
%
1.58
266
2804
16
104
1.55
0.85
1.5
1.6
—
—
—
0
0
50
400
1.27
0.83
1.2
1.2
121.15
161.46
u/ml
0.37
25
157
10
165
0.60
0.82
1.2
1.3
—
106.50
—
0
20
6
32
1.88
0.82
1.5
3.6
1545.17
892.06
u/ml
—
6
32
285
3051
0.89
0.80
7.5
6.3
26.78
27.55
%
0.48
273
2898
485
4656
1.13
0.80
4.6
4.3
15.19
14.84
pmol/l
2.26
447
4236
10
58
1.73
0.80
2.5
1.5
516.60
287.22
mu/l
—
10
46
298
2782
1.12
0.80
15.9
11.5
0.00
0.01
e9/l
0.67
257
2277
623
6361
0.84
0.79
39.6
25.6
130.06
134.14
g/l
9.69
614
6287
128
1131
1.16
0.79
3.8
3.2
1.33
0.99
e6/l
0.48
86
607
11
66
1.68
0.79
1.0
1.2
—
—
—
0
0
150
1344
1.15
0.77
6.2
5.0
—
—
—
0
0
226
2080
1.13
0.76
2.9
3.3
1045.87
1439.95
ng/l
1.04
193
1795
623
6358
0.85
0.76
39.0
25.3
30.10
30.31
pg
1.81
612
6285
623
6358
0.85
0.76
39.6
25.9
39.10
40.06
%
5.68
612
6280
623
6358
0.85
0.76
39.2
25.4
4.35
4.46
e12/l
6.33
610
6211
623
6358
0.85
0.76
39.2
25.4
7.20
6.82
e9/l
4.11
609
6210
15
99
1.53
0.76
3.7
3.0
5.77
4.37
e9/l
0.51
15
99
64
534
1.22
0.75
3.3
3.9
85.00
83.95
ng/l
0.03
55
473
42
334
1.27
0.75
2.9
3.3
4.56
4.48
pmol/l
0.20
37
294
281
3001
0.90
0.74
7.8
6.5
8.88
8.95
%
0.14
270
2821
623
6356
0.85
0.74
39.1
25.3
90.72
91.12
fl
1.22
612
6284
623
6356
0.85
0.74
39.2
25.4
259.41
248.19
e9/l
3.54
610
6231
56
674
0.82
0.74
4.1
4.1
5.51
26.56
ug/l
1.10
48
564
47
576
0.80
0.73
4.0
4.1
7.20
7.36
ph
1.17
34
411
157
1734
0.88
0.73
5.1
3.3
0.00
0.04
—
6
45
66
556
1.21
0.71
4.9
4.7
1.32
0.93
%
0.40
25
184
13
85
1.54
0.69
2.3
1.9
32.31
32.54
pg
0.07
13
85
10
61
1.65
0.68
1.4
1.2
—
—
—
0
0
72
616
1.19
0.67
1.9
2.4
0.21
0.21
g/l
0.14
64
576
12
178
0.67
0.65
1.8
1.9
37.58
41.51
nmol/l
0.23
12
169
155
1410
1.13
0.64
2.0
1.8
2.01
1.36
mg/l
0.51
125
1113
191
2066
0.90
0.63
4.3
4.1
11.41
9.06
mg/mmol
0.21
124
1293
6
104
0.57
0.62
1.0
1.1
—
19.20
—
0
25
10
63
1.60
0.62
3.2
2.1
—
—
—
0
0
131
1447
0.88
0.62
1.3
1.3
1.00
1.87
u/ml
0.98
46
355
0
21
0.00
0.60
0.0
1.2
—
138.50
—
0
16
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
298
2821
1.10
0.58
2.7
2.5
75.32
78.01
nmol/l
0.93
275
2527
26
202
1.30
0.58
4.8
4.3
15.97
2.80
ratio
0.42
17
114
11
161
0.68
0.57
1.3
1.4
—
—
—
0
0
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
5
88
0.57
0.56
1.2
1.2
—
—
—
0
0
67
768
0.86
0.55
2.6
3.0
6.91
7.57
umol/l
0.15
53
685
19
248
0.76
0.52
1.1
1.6
0.54
0.34
mg/l
—
6
111
51
595
0.85
0.52
2.8
2.4
28.87
32.70
u/l
0.64
40
487
168
1809
0.91
0.51
4.3
5.5
3.39
2.61
ug/l
0.31
146
1616
6
41
1.47
0.50
2.7
1.3
21.17
30.55
%
—
6
25
24
301
0.79
0.49
1.1
1.1
—
71.22
—
0
9
37
442
0.83
0.49
1.3
1.4
—
—
—
0
0
19
145
1.32
0.49
2.4
1.6
—
—
—
0
0
112
1018
1.12
0.49
2.8
2.5
2.26
2.29
g/l
0.15
103
948
10
68
1.48
0.47
3.3
1.3
8.59
29.74
u/l
—
10
57
10
68
1.48
0.47
1.3
5.7
9.37
11.05
%
—
10
68
24
191
1.27
0.47
1.3
1.4
—
—
—
0
0
119
1089
1.11
0.46
2.8
2.5
10.94
12.74
umol/l
1.89
109
1016
8
117
0.68
0.46
1.4
1.4
—
—
—
0
0
60
528
1.15
0.43
4.9
4.8
0.32
0.14
%
0.36
19
154
73
814
0.89
0.42
1.6
1.6
—
—
—
0
0
53
464
1.15
0.42
3.5
2.7
—
—
—
0
0
295
2826
1.07
0.41
2.3
2.2
94.63
95.27
pmol/l
0.09
169
1455
5
34
1.47
0.40
1.6
1.1
130.20
152.39
nmol/l
—
5
34
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
25
205
1.23
0.39
1.4
1.5
—
—
—
0
0
5
35
1.43
0.39
5.8
2.6
—
—
—
0
0
59
526
1.13
0.37
3.1
3.3
168.61
209.68
ng/l
0.43
51
480
15
191
0.78
0.37
1.3
1.2
—
—
—
0
0
5
78
0.64
0.35
1.0
1.1
1.29
1.47
g/l
—
5
69
6
42
1.43
0.35
1.3
1.9
11.87
12.63
umol/l
—
6
37
114
1060
1.09
0.34
4.2
3.3
3.01
2.09
e6/l
0.42
71
532
19
154
1.24
0.34
1.3
1.9
4.47
5.51
iu/l
—
8
58
61
549
1.12
0.34
5.5
5.0
0.10
0.19
%
0.42
20
150
59
530
1.12
0.34
4.7
4.7
1.50
0.63
%
0.83
20
170
6
45
1.34
0.34
2.2
2.1
549.17
542.06
e6/l
—
6
31
6
46
1.31
0.33
2.2
2.3
138.00
225.26
e6/l
—
6
35
6
46
1.31
0.33
1.5
3.0
7.63
8.33
mmol/l
—
6
46
20
164
1.23
0.33
1.3
1.3
164.57
234.29
miu/ml
—
7
77
146
1547
0.93
0.32
2.8
2.9
332.26
346.61
umol/l
0.92
130
1343
7
97
0.72
0.31
1.0
1.2
—
—
—
0
0
25
212
1.19
0.30
12.5
5.8
1.84
1.47
mg/l
1.02
25
188
322
3318
0.95
0.29
7.9
6.5
0.18
0.19
e9/l
0.78
291
2884
25
213
1.18
0.29
1.4
1.5
—
—
—
0
0
7
57
1.23
0.29
1.4
1.1
—
—
—
0
0
41
459
0.89
0.28
1.5
1.7
—
—
—
0
0
208
2167
0.94
0.28
3.6
3.4
7.08
7.48
mmol/l
0.67
182
1833
25
215
1.17
0.27
1.4
1.5
—
—
—
0
0
35
310
1.14
0.26
1.9
2.1
—
—
—
0
0
61
664
0.91
0.26
1.4
1.6
—
—
—
0
0
5
75
0.66
0.26
1.4
1.1
—
—
—
0
0
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
19
160
1.19
0.25
6.5
4.9
—
—
—
0
0
313
3217
0.95
0.25
7.6
6.2
0.60
0.59
e9/l
0.27
281
2744
540
5471
0.95
0.23
5.7
5.4
1.98
1.96
mu/l
0.13
500
5024
479
4865
0.95
0.22
35.4
22.0
331.67
332.10
g/l
0.44
471
4836
41
372
1.11
0.22
1.3
1.4
—
36.67
—
0
25
315
3228
0.96
0.22
7.7
6.2
0.04
0.04
e9/l
0.40
284
2760
14
116
1.21
0.22
1.4
1.4
175.13
255.46
u/ml
—
8
54
99
936
1.07
0.22
3.0
2.5
19.13
22.52
%
1.73
91
878
378
3857
0.96
0.21
3.5
3.4
52.42
47.71
u/l
0.47
356
3622
0
12
0.00
0.21
0.0
3.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
5
43
1.16
0.21
1.8
1.6
79.60
80.28
umol/l
—
5
43
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.3
—
5621.31
—
0
13
0
13
0.00
0.21
0.0
1.8
—
9.80
—
0
5
11
134
0.82
0.20
1.1
1.2
—
—
—
0
0
21
183
1.15
0.20
4.2
3.1
2.70
2.34
index
—
10
96
6
48
1.25
0.20
1.5
1.3
—
—
—
0
0
29
323
0.89
0.20
1.5
1.3
—
—
—
0
0
6
50
1.20
0.19
1.0
1.2
96.17
104.92
pmol/l
—
6
50
6
50
1.20
0.19
2.2
3.0
2538.33
1010.56
mg
—
6
50
24
214
1.13
0.17
1.4
1.5
—
—
—
0
0
7
61
1.15
0.17
1.3
1.2
1.66
1.51
nmol/l
—
7
55
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
6
80
0.75
0.15
1.3
1.3
—
—
—
0
0
25
275
0.91
0.14
3.8
1.9
13.08
7.72
iu/ml
—
9
63
11
127
0.86
0.12
2.1
3.7
28.74
2233.75
u/ml
0.61
11
121
16
143
1.12
0.11
4.8
2.8
62.94
58.84
%
0.52
16
143
219
2150
1.03
0.10
6.9
6.2
—
—
—
0
0
19
208
0.91
0.10
1.1
1.4
349.08
291.54
ug/g
0.92
13
122
5
45
1.11
0.10
1.8
2.4
800.40
555.00
ml
—
5
26
95
979
0.97
0.09
1.7
1.8
—
—
—
0
0
23
213
1.08
0.09
1.4
1.5
—
—
—
0
0
323
3268
0.98
0.09
7.6
6.3
1.85
1.95
e9/l
0.65
293
2878
6
57
1.05
0.08
3.2
3.0
—
—
—
0
0
210
2067
1.02
0.08
3.8
3.3
53.91
33.48
u/l
0.45
199
1953
282
2855
0.98
0.08
3.2
3.0
118.59
124.18
ug/l
0.17
250
2642
5
60
0.83
0.08
2.6
1.4
91.80
60.45
%
—
5
42
80
776
1.03
0.08
5.9
3.1
4.03
5.71
e9/l
1.23
68
678
188
1911
0.98
0.08
8.7
6.1
—
—
—
0
0
7
66
1.06
0.08
1.0
1.3
—
—
nmol/l
—
0
0
6
71
0.84
0.07
1.5
1.4
—
—
—
0
0
8
74
1.08
0.07
1.1
1.4
6.04
6.34
mmol/l
—
8
69
8
75
1.07
0.07
3.1
1.8
—
—
—
0
0
13
143
0.91
0.07
2.1
2.5
112.04
87.51
ug/min
—
8
88
7
83
0.84
0.07
1.6
1.2
—
112.54
—
0
5
52
502
1.04
0.06
5.1
2.7
6.04
6.10
ph
0.22
35
345
13
142
0.91
0.06
3.5
3.4
0.85
0.85
nmol/l
0.02
13
116
9
104
0.86
0.06
1.1
1.1
—
—
—
0
0
13
119
1.09
0.06
1.5
1.4
—
—
—
0
0
11
100
1.10
0.05
1.1
1.1
—
—
—
0
0
36
373
0.96
0.04
10.9
4.6
—
—
—
0
0
620
6184
1.02
0.04
31.9
22.1
74.64
77.98
umol/l
1.77
610
6108
30
310
0.97
0.03
3.2
2.5
—
—
—
0
0
10
92
1.09
0.03
2.8
2.7
—
—
—
0
0
11
102
1.08
0.03
1.8
1.6
—
—
—
0
0
25
242
1.03
0.02
1.3
1.2
0.30
1.94
u/ml
—
6
15
25
242
1.03
0.02
1.6
2.3
9.46
10.18
g/l
0.56
20
216
356
3572
0.99
0.02
13.1
9.5
4.42
4.16
e9/l
1.03
325
3105
601
6002
1.01
0.01
26.0
14.9
—
—
—
0
0
31
313
0.99
0.00
3.6
2.9
43.44
100.43
u/ml
0.77
31
301
10
99
1.01
0.00
1.6
1.1
—
—
—
0
0
10
99
1.01
0.00
1.6
1.1
—
—
—
0
0
17
169
1.01
0.00
1.2
1.2
—
—
—
0
0
25
251
1.00
0.00
2.0
3.0
—
—
—
0
0
7
75
0.93
0.00
1.4
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
4.34
—
0
7
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
105.00
—
0
7
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
0.53
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
4.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
8.04
—
0
6
0
9
0.00
0.00
0.0
1.0
—
18.27
—
0
9
9
99
0.91
-0.00
3.3
4.2
4.33
1.57
%
—
9
91
5
54
0.93
-0.00
1.6
2.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
91
0.99
-0.00
1.6
1.5
33.29
32.03
g/l
—
9
82
7
72
0.97
-0.00
1.7
1.2
—
—
—
0
0
77
770
1.00
-0.00
1.6
1.4
—
—
—
0
0
6
61
0.98
-0.00
1.0
1.1
—
—
—
0
0
7
71
0.99
-0.00
1.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.6
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
60
1.00
-0.00
2.0
1.2
3650.67
147006.14
e6/l
—
6
42
5
55
0.91
-0.00
1.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_HCOTHUNS and mortality.

Females

Parameter HR [95% CI] p-value
G6_HCOTHUNS 3.018 [2.63, 3.46] < 0.001
Birth year 0.998 [0.99, 1.01] 0.569

During the follow-up period (1.1.1998 — 31.12.2019), 789 out of 2228 females with G6_HCOTHUNS died.

Males

Parameter HR [95% CI] p-value
G6_HCOTHUNS 3.131 [2.67, 3.68] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 826 out of 2254 males with G6_HCOTHUNS died.

Mortality risk

Mortality risk for people of age

years, who have G6_HCOTHUNS.

N-year risk Females Males
1 0.299% 0.595%
5 2.223% 3.345%
10 5.219% 8.599%
15 10.012% 15.221%
20 16.312% 24.269%

Relationships between endpoints

↥

Index endpoint: G6_HCOTHUNS – Other and unspecified hydrocephalus

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data